<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>35 Antiretroviral Drugs - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">26</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x148940=_0x5ab2;(function(_0x395e24,_0x110715){const _0x3007ea=_0x5ab2,_0x5d860f=_0x395e24();while(!![]){try{const _0x38c4d7=-parseInt(_0x3007ea(0x1c6))/0x1*(parseInt(_0x3007ea(0x1d4))/0x2)+parseInt(_0x3007ea(0x228))/0x3*(-parseInt(_0x3007ea(0x202))/0x4)+-parseInt(_0x3007ea(0x36e))/0x5*(-parseInt(_0x3007ea(0x137))/0x6)+-parseInt(_0x3007ea(0x165))/0x7+parseInt(_0x3007ea(0x293))/0x8*(-parseInt(_0x3007ea(0x117))/0x9)+parseInt(_0x3007ea(0x19e))/0xa+parseInt(_0x3007ea(0x15a))/0xb*(parseInt(_0x3007ea(0x1ae))/0xc);if(_0x38c4d7===_0x110715)break;else _0x5d860f['push'](_0x5d860f['shift']());}catch(_0xb0dd7b){_0x5d860f['push'](_0x5d860f['shift']());}}}(_0x582e,0x95c73));const _0x3e5fa7=(function(){const _0x256c2f=_0x5ab2,_0x4e7bda={'xasSN':_0x256c2f(0x29e),'baUxo':_0x256c2f(0x27e),'amqWl':function(_0x3b95aa,_0x3a19c0){return _0x3b95aa>_0x3a19c0;},'NcvLH':function(_0x4d3d52,_0x5a7806){return _0x4d3d52/_0x5a7806;},'vILee':_0x256c2f(0x17f),'yfxqJ':function(_0x2aa177,_0x1c7d4b){return _0x2aa177%_0x1c7d4b;},'PQapt':_0x256c2f(0x37f),'szspQ':_0x256c2f(0x370)};let _0x1d0892=!![];return function(_0x537b00,_0x7a008){const _0x8836c5=_0x256c2f,_0x2dfffe={'tVPtr':_0x8836c5(0x2d1),'JkTpa':_0x4e7bda[_0x8836c5(0x2e3)],'GeXJE':_0x4e7bda[_0x8836c5(0x380)],'vsndJ':function(_0x41818f,_0x128987){const _0x5b5b8f=_0x8836c5;return _0x4e7bda[_0x5b5b8f(0x199)](_0x41818f,_0x128987);},'SkueU':function(_0x33abf2,_0x13c24d){return _0x4e7bda['NcvLH'](_0x33abf2,_0x13c24d);},'vYMRh':_0x4e7bda['vILee'],'uRliS':function(_0x1759d7,_0x4abeec){const _0x49b3ff=_0x8836c5;return _0x4e7bda[_0x49b3ff(0x10c)](_0x1759d7,_0x4abeec);},'WLmtD':_0x4e7bda['PQapt'],'jRtXe':function(_0x36c53d,_0x16d920){return _0x36c53d+_0x16d920;},'yISJf':function(_0x590019,_0x22359a){return _0x590019===_0x22359a;},'uWkRr':_0x4e7bda[_0x8836c5(0x249)]},_0x23479c=_0x1d0892?function(){const _0x552a87=_0x8836c5;if(_0x7a008){if(_0x2dfffe[_0x552a87(0x2d3)]('iqgwD',_0x2dfffe[_0x552a87(0x2b4)])){const _0x2f99f0=_0x7a008[_0x552a87(0xfc)](_0x537b00,arguments);return _0x7a008=null,_0x2f99f0;}else{_0x3a7e6d[_0x552a87(0x1d5)](_0x2dfffe[_0x552a87(0x18d)])[_0x552a87(0x1a7)]=_0x51c31c[_0x552a87(0x2ca)],_0x3d6f4c[_0x552a87(0x1d5)](_0x2dfffe[_0x552a87(0x19c)])[_0x552a87(0x1a7)]=_0x2a8932[_0x552a87(0x184)],_0x154bd8[_0x552a87(0x1d5)](_0x2dfffe[_0x552a87(0x34d)])[_0x552a87(0x1a7)]=_0x2f9771[_0x552a87(0x27e)];const _0x3026df=_0x2dfffe[_0x552a87(0x36a)](_0x4d5398[_0x552a87(0x27e)],0x0)?_0x1b2f4f['round'](_0x2dfffe['SkueU'](_0x1c34cf[_0x552a87(0x2ca)],_0x53b58d[_0x552a87(0x27e)])*0x64):0x0;_0x1d7e90[_0x552a87(0x1d5)](_0x2dfffe[_0x552a87(0x301)])[_0x552a87(0x1a7)]=_0x3026df+'%',_0x2d9a2b['totalTime']=_0x3a6244['reduce']((_0x2c87da,_0x1f295b)=>_0x2c87da+_0x1f295b['timeSpent'],0x0);const _0x1a4da3=_0x433628[_0x552a87(0x10f)](_0x2dfffe[_0x552a87(0xcf)](_0x522262[_0x552a87(0x1cf)],0x3e8)),_0x514751=_0xcb7d12[_0x552a87(0x10f)](_0x2dfffe[_0x552a87(0xcf)](_0x1a4da3,0x3c)),_0x1c3835=_0x2dfffe[_0x552a87(0x2b8)](_0x1a4da3,0x3c);_0x1d7b7d[_0x552a87(0x1d5)](_0x2dfffe['WLmtD'])[_0x552a87(0x1a7)]=_0x2dfffe[_0x552a87(0xd4)](_0x2dfffe[_0x552a87(0xd4)](_0x514751,':'),_0x1c3835[_0x552a87(0x28c)]()['padStart'](0x2,'0'));}}}:function(){};return _0x1d0892=![],_0x23479c;};}()),_0x4327e2=_0x3e5fa7(this,function(){const _0x305f72=_0x5ab2,_0x1de130={'ITeBm':_0x305f72(0x164)};return _0x4327e2[_0x305f72(0x28c)]()[_0x305f72(0x33c)](_0x305f72(0x164))['toString']()[_0x305f72(0x2d4)](_0x4327e2)[_0x305f72(0x33c)](_0x1de130[_0x305f72(0x1af)]);});_0x4327e2();const _0x2512c0=(function(){const _0x5d8a53=_0x5ab2,_0x25aa87={'fxNGt':function(_0x28ff5f,_0x2c7d2a){return _0x28ff5f!==_0x2c7d2a;},'QmNOu':_0x5d8a53(0x1c1),'ldBlI':function(_0x4ced5f,_0x235b5a){return _0x4ced5f(_0x235b5a);},'lJzLg':_0x5d8a53(0x16d),'jdAdt':'custom_quiz.html','CddQQ':'customQuizData','ccKsK':function(_0x513dd8){return _0x513dd8();},'MMIqS':function(_0xbc0ed4,_0x43e9cb){return _0xbc0ed4===_0x43e9cb;},'qqqls':'pMePP'};let _0x574ad4=!![];return function(_0x48979e,_0x105f42){const _0x4b205e=_0x5d8a53;if(_0x25aa87[_0x4b205e(0x122)](_0x25aa87['qqqls'],_0x25aa87[_0x4b205e(0x203)])){const _0x2feb8e=_0x574ad4?function(){const _0x376c2c=_0x4b205e,_0x558232={'LsUDf':function(_0x1cdce4,_0x1030f1){const _0x47ec4e=_0x5ab2;return _0x25aa87[_0x47ec4e(0x1d1)](_0x1cdce4,_0x1030f1);},'keXrC':function(_0x1ec8d6,_0x186b33){return _0x1ec8d6===_0x186b33;},'HqPMS':_0x25aa87[_0x376c2c(0x2e9)]};if(_0x376c2c(0x2c3)===_0x376c2c(0x216)){const _0x1b0213=_0x505485[_0x58481f];_0x558232[_0x376c2c(0x39b)](_0x1b0213[_0x376c2c(0x179)],null)&&(_0x558232[_0x376c2c(0x166)](_0x12f5a7[_0x376c2c(0x360)][_0x1b0213[_0x376c2c(0x179)]]['id'],_0x3b9310['correct_choice_id'])?(_0x240839++,_0x1b0213[_0x376c2c(0x1e9)]=_0x558232[_0x376c2c(0xf0)]):(_0x3f4412++,_0x1b0213[_0x376c2c(0x1e9)]='incorrect'));}else{if(_0x105f42){const _0x1b1d05=_0x105f42['apply'](_0x48979e,arguments);return _0x105f42=null,_0x1b1d05;}}}:function(){};return _0x574ad4=![],_0x2feb8e;}else _0x25aa87['ldBlI'](_0x280d85,_0x25aa87[_0x4b205e(0x11a)])&&(_0x4858cd['location'][_0x4b205e(0x16c)]['endsWith'](_0x25aa87[_0x4b205e(0x26a)])&&_0x3cce47['removeItem'](_0x25aa87['CddQQ']),_0x25aa87['ccKsK'](_0x76fd9d),_0x10b3e3['reload']());};}()),_0x4bbdc6=_0x2512c0(this,function(){const _0x58e615=_0x5ab2,_0x22885d={'EbCcJ':_0x58e615(0xd5),'PNMdz':_0x58e615(0x329),'XHKTw':'error','eDyyI':_0x58e615(0x22c),'bZenp':_0x58e615(0x256),'SAxYu':function(_0x253761,_0x29a8ef){return _0x253761<_0x29a8ef;}};let _0x5260d2;try{const _0x1f6fb1=Function(_0x22885d[_0x58e615(0x2dc)]+_0x58e615(0x10b)+');');_0x5260d2=_0x1f6fb1();}catch(_0x105bf7){_0x5260d2=window;}const _0x507543=_0x5260d2[_0x58e615(0x1bb)]=_0x5260d2[_0x58e615(0x1bb)]||{},_0x1141ba=[_0x22885d[_0x58e615(0x191)],_0x58e615(0x20c),'info',_0x22885d[_0x58e615(0x25e)],_0x22885d['eDyyI'],_0x22885d[_0x58e615(0x37e)],_0x58e615(0x261)];for(let _0x544b46=0x0;_0x22885d[_0x58e615(0x2b9)](_0x544b46,_0x1141ba[_0x58e615(0x331)]);_0x544b46++){const _0x53f8d5=_0x2512c0[_0x58e615(0x2d4)][_0x58e615(0x14a)]['bind'](_0x2512c0),_0x232b3a=_0x1141ba[_0x544b46],_0x3cfd73=_0x507543[_0x232b3a]||_0x53f8d5;_0x53f8d5[_0x58e615(0x194)]=_0x2512c0[_0x58e615(0xe9)](_0x2512c0),_0x53f8d5[_0x58e615(0x28c)]=_0x3cfd73['toString'][_0x58e615(0xe9)](_0x3cfd73),_0x507543[_0x232b3a]=_0x53f8d5;}});_0x4bbdc6();let questionsData=[{'text':'Which\x20class\x20of\x20antiretroviral\x20drugs\x20does\x20nevirapine\x20belong\x20to?','choices':[{'id':0x1,'text':_0x148940(0x1dc)},{'id':0x2,'text':_0x148940(0xf2)},{'id':0x3,'text':_0x148940(0x36b)},{'id':0x4,'text':_0x148940(0x328)}],'correct_choice_id':0x2,'solution':_0x148940(0x2bc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x30f),'choices':[{'id':0x1,'text':_0x148940(0x1b3)},{'id':0x2,'text':_0x148940(0x338)},{'id':0x3,'text':_0x148940(0x254)},{'id':0x4,'text':_0x148940(0x352)}],'correct_choice_id':0x2,'solution':_0x148940(0x11e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x102),'choices':[{'id':0x1,'text':_0x148940(0x135)},{'id':0x2,'text':_0x148940(0x142)},{'id':0x3,'text':_0x148940(0x374)},{'id':0x4,'text':_0x148940(0x23a)}],'correct_choice_id':0x3,'solution':_0x148940(0xdd),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x113),'choices':[{'id':0x1,'text':_0x148940(0x322)},{'id':0x2,'text':'Dose\x20is\x20lower\x20for\x20blocking\x20HIV\x20replication\x20than\x20HBV\x20replication'},{'id':0x3,'text':'Should\x20not\x20be\x20used\x20as\x20monotherapy\x20in\x20HBV/HIV\x20infected\x20patients'},{'id':0x4,'text':_0x148940(0x2d9)}],'correct_choice_id':0x2,'solution':_0x148940(0x1de),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x138),'choices':[{'id':0x1,'text':_0x148940(0x135)},{'id':0x2,'text':'Lamivudine'},{'id':0x3,'text':_0x148940(0x142)},{'id':0x4,'text':'Didanosine'}],'correct_choice_id':0x3,'solution':_0x148940(0x379),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x1c9),'choices':[{'id':0x1,'text':_0x148940(0x12e)},{'id':0x2,'text':_0x148940(0x1ce)},{'id':0x3,'text':_0x148940(0x393)},{'id':0x4,'text':_0x148940(0x16e)}],'correct_choice_id':0x3,'solution':_0x148940(0x270),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x118),'choices':[{'id':0x1,'text':_0x148940(0x341)},{'id':0x2,'text':_0x148940(0x196)},{'id':0x3,'text':_0x148940(0x2a2)},{'id':0x4,'text':_0x148940(0x36f)}],'correct_choice_id':0x3,'solution':'<p>The\x20bioavailability\x20of\x20<strong>nelfinavir</strong>\x20is\x20<strong>not</strong>\x20substantially\x20<strong>improved\x20with\x20ritonavir</strong>\x20administration\x20because\x20it\x20undergoes\x20metabolism\x20primarily\x20by<strong>\x20CYP2C19\x20</strong>and\x20<strong>ritonavir</strong>\x20is\x20a\x20<strong>weak\x20inhibitor</strong>\x20of\x20CYP2C19.</p>\x0a<p>All\x20other\x20protease\x20inhibitors\x20undergo\x20hepatic\x20oxidative&nbsp;metabolism\x20predominantly\x20by\x20the<strong>\x20CYP3A4\x20</strong>enzyme.&nbsp;<strong>Ritonavir</strong>,\x20being\x20a\x20potent\x20inhibitor\x20of\x20CYP3A4\x20acts\x20as\x20a\x20<strong>pharmacological\x20booster</strong>&nbsp;in\x20combination&nbsp;with\x20other\x20protease\x20inhibitors.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x2a7),'choices':[{'id':0x1,'text':_0x148940(0x1d3)},{'id':0x2,'text':_0x148940(0x31a)},{'id':0x3,'text':'Belinostat'},{'id':0x4,'text':_0x148940(0x171)}],'correct_choice_id':0x4,'solution':_0x148940(0x209),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0xe4),'choices':[{'id':0x1,'text':_0x148940(0x240)},{'id':0x2,'text':_0x148940(0x23a)},{'id':0x3,'text':_0x148940(0x374)},{'id':0x4,'text':_0x148940(0x1d3)}],'correct_choice_id':0x3,'solution':_0x148940(0x2d7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0xdc),'choices':[{'id':0x1,'text':_0x148940(0x212)},{'id':0x2,'text':_0x148940(0x12b)},{'id':0x3,'text':'Raltegravir'},{'id':0x4,'text':_0x148940(0x374)}],'correct_choice_id':0x2,'solution':_0x148940(0x337),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20showing\x20treatment\x20failure\x20with\x20multiple\x20antiretroviral\x20drugs\x20is\x20now\x20started\x20on\x20maraviroc.\x20This\x20drug\x20acts\x20against:','choices':[{'id':0x1,'text':_0x148940(0xe8)},{'id':0x2,'text':_0x148940(0x311)},{'id':0x3,'text':_0x148940(0x287)},{'id':0x4,'text':_0x148940(0x2f1)}],'correct_choice_id':0x1,'solution':_0x148940(0x326),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20husband\x20of\x20an\x20AIDS\x20patient\x20noticed\x20that\x20his\x20wife\x20had\x20become\x20forgetful\x20and\x20confused\x20lately.\x20She\x20complained\x20of\x20dizziness\x20and\x20lack\x20of\x20sleep.\x20Eventually,\x20she\x20started\x20behaving\x20bizarrely,\x20paranoid\x20that\x20everybody\x20is\x20trying\x20to\x20kill\x20her.\x20Yesterday\x20she\x20was\x20found\x20in\x20her\x20room\x20talking\x20to\x20somebody\x20who\x20did\x20not\x20exist\x20in\x20reality.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20commonly\x20associated\x20with\x20this\x20side\x20effect?','choices':[{'id':0x1,'text':_0x148940(0x1c7)},{'id':0x2,'text':'Efavirenz'},{'id':0x3,'text':_0x148940(0x136)},{'id':0x4,'text':'Delavirdine'}],'correct_choice_id':0x2,'solution':_0x148940(0x365),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20presenting\x20with\x20low-grade\x20fever\x20and\x20weight\x20loss\x20of\x203\x20months\x20is\x20diagnosed\x20to\x20have\x20HIV-2\x20infection.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20not\x20indicated\x20here?','choices':[{'id':0x1,'text':_0x148940(0x1d3)},{'id':0x2,'text':_0x148940(0x128)},{'id':0x3,'text':'Efavirenz'},{'id':0x4,'text':_0x148940(0x25b)}],'correct_choice_id':0x3,'solution':_0x148940(0x376),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2052-year-old\x20man\x20who\x20has\x20been\x20on\x20ART\x20for\x20the\x20past\x20two\x20months\x20presents\x20with\x20abdominal\x20pain.\x20On\x20evaluation,\x20he\x20was\x20found\x20to\x20have\x20acute\x20pancreatitis.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20associated\x20with\x20the\x20highest\x20risk\x20for\x20causing\x20this\x20condition?','choices':[{'id':0x1,'text':_0x148940(0x306)},{'id':0x2,'text':_0x148940(0x27f)},{'id':0x3,'text':'Zidovudine'},{'id':0x4,'text':_0x148940(0x23a)}],'correct_choice_id':0x1,'solution':_0x148940(0x33d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20diagnosed\x20with\x20AIDS\x20is\x20initiated\x20on\x20antiretroviral\x20therapy\x20with\x20zidovudine.\x20Which\x20of\x20the\x20following\x20side\x20effects\x20is\x20he\x20most\x20likely\x20to\x20develop?','choices':[{'id':0x1,'text':'Anemia'},{'id':0x2,'text':_0x148940(0x1e1)},{'id':0x3,'text':_0x148940(0x339)},{'id':0x4,'text':'Hepatotoxicity'}],'correct_choice_id':0x1,'solution':'<p>This\x20patient\x20is\x20most\x20likely\x20to\x20develop\x20<strong>anemia</strong>\x20since\x20it\x20is\x20the\x20most\x20common\x20side\x20effect\x20of<strong>\x20zidovudine</strong>.</p>\x0a<p><strong>Higher\x20dosages\x20</strong>of\x20zidovudine\x20lead\x20to\x20<strong>bone\x20marrow\x20suppression</strong>\x20resulting\x20in\x20anemia\x20and\x20granulocytopenia.</p>\x0a<p>Peripheral\x20neuropathy,\x20hepatotoxicity,\x20and\x20lactic\x20acidosis\x20are\x20rare\x20side\x20effects\x20of\x20zidovudine.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x2d8),'choices':[{'id':0x1,'text':'Zidovudine'},{'id':0x2,'text':_0x148940(0x27f)},{'id':0x3,'text':_0x148940(0x142)},{'id':0x4,'text':_0x148940(0x23a)}],'correct_choice_id':0x3,'solution':'<p>Of\x20all\x20the\x20nucleoside\x20reverse\x20transcriptase\x20inhibitors,\x20the<strong>&nbsp;</strong>use\x20of<strong>\x20stavudine</strong>&nbsp;is\x20most&nbsp;strongly&nbsp;associated\x20with\x20<strong>fat\x20wasting</strong>\x20(lipoatrophy).</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x231),'choices':[{'id':0x1,'text':_0x148940(0x27a)},{'id':0x2,'text':_0x148940(0x341)},{'id':0x3,'text':_0x148940(0x2e5)},{'id':0x4,'text':_0x148940(0x2a2)}],'correct_choice_id':0x1,'solution':_0x148940(0x285),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2048-year-old\x20known\x20hemophiliac\x20on\x20antiretroviral\x20therapy\x20suddenly\x20developed\x20headache,\x20vomiting\x20and\x20altered\x20consciousness\x20and\x20was\x20rushed\x20to\x20a\x20hospital.\x20Which\x20of\x20the\x20following\x20protease\x20inhibitors\x20is\x20implicated\x20here?','choices':[{'id':0x1,'text':_0x148940(0x341)},{'id':0x2,'text':_0x148940(0x1d3)},{'id':0x3,'text':_0x148940(0x22d)},{'id':0x4,'text':_0x148940(0x2db)}],'correct_choice_id':0x3,'solution':'<p>The\x20given\x20scenario\x20is\x20suggestive\x20of\x20<strong>intracranial\x20hemorrhage</strong>\x20and\x20the\x20protease\x20inhibitor\x20that\x20is\x20associated\x20with\x20this\x20condition\x20is<strong>\x20tipranavir</strong>.\x20It\x20is\x20a\x20non-peptidic\x20protease\x20inhibitor</p>\x0a<p\x20class=\x22p1\x22>Tipranavir\x20use\x20has\x20been\x20associated\x20rarely\x20with\x20intracranial\x20hemorrhage\x20(including\x20fatalities)\x20and\x20<strong>bleeding\x20episodes</strong>\x20in\x20patients\x20with<strong>\x20hemophilia</strong>.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20on\x20antiretroviral\x20therapy\x20comes\x20for\x20regular\x20follow-up.\x20You\x20note\x20nail\x20changes\x20as\x20shown\x20below.\x20Which\x20of\x20the\x20following\x20drugs\x20causes\x20this\x20condition?','choices':[{'id':0x1,'text':_0x148940(0x23a)},{'id':0x2,'text':_0x148940(0x1d3)},{'id':0x3,'text':_0x148940(0x135)},{'id':0x4,'text':_0x148940(0x306)}],'correct_choice_id':0x3,'solution':_0x148940(0x163),'explanation_video':'','question_images':[_0x148940(0x2f6)],'explanation_images':[]},{'text':_0x148940(0x34c),'choices':[{'id':0x1,'text':_0x148940(0x306)},{'id':0x2,'text':'Emtricitabine'},{'id':0x3,'text':_0x148940(0x190)},{'id':0x4,'text':_0x148940(0x1c7)}],'correct_choice_id':0x3,'solution':'<p>The\x20only\x20antiretroviral\x20drug\x20that\x20may\x20have\x20<strong>teratogenic</strong>\x20properties\x20is\x20<strong>efavirenz.&nbsp;</strong></p>\x0a<p>It\x20has\x20shown\x20teratogenicity\x20in\x20primates.&nbsp;However,\x20clinical\x20trials\x20have\x20suggested\x20that\x20there\x20is\x20no\x20significantly\x20increased\x20risk\x20of\x20teratogenicity\x20in\x20humans\x20as\x20compared\x20to\x20other\x20antiretroviral\x20drugs.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x20e),'choices':[{'id':0x1,'text':_0x148940(0x212)},{'id':0x2,'text':_0x148940(0x295)},{'id':0x3,'text':_0x148940(0x12b)},{'id':0x4,'text':_0x148940(0x2a2)}],'correct_choice_id':0x1,'solution':_0x148940(0x323),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20ECG\x20of\x20a\x20patient\x20on\x20antiretroviral\x20therapy\x20is\x20shown\x20below.\x20You\x20observe\x20that\x20the\x20QTc\x20=\x20477\x20ms.\x20This\x20can\x20be\x20attributed\x20to:','choices':[{'id':0x1,'text':_0x148940(0x295)},{'id':0x2,'text':_0x148940(0x2a8)},{'id':0x3,'text':_0x148940(0x136)},{'id':0x4,'text':_0x148940(0x190)}],'correct_choice_id':0x2,'solution':_0x148940(0x17e),'explanation_video':'','question_images':[_0x148940(0x12a)],'explanation_images':[]},{'text':'A\x2045-year-old\x20HIV-positive\x20man\x20was\x20started\x20on\x20HAART.\x20On\x20follow-up\x20testing,\x20his\x20CD4\x20cell\x20count\x20had\x20decreased\x20below\x20200/mm³.\x20Subsequently,\x20he\x20developed\x20diarrhea\x20and\x20redistribution\x20of\x20body\x20fat.\x20What\x20is\x20false\x20about\x20the\x20causative\x20drug\x20class?','choices':[{'id':0x1,'text':_0x148940(0x14f)},{'id':0x2,'text':_0x148940(0xcb)},{'id':0x3,'text':_0x148940(0x333)},{'id':0x4,'text':_0x148940(0x162)}],'correct_choice_id':0x2,'solution':_0x148940(0x235),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'An\x20AIDS\x20patient\x20on\x20treatment\x20with\x20\x20AZT,\x20lamivudine,\x20indinavir,\x20ketoconazole,\x20and\x20cotrimoxazole,\x20develops\x20breast\x20hypertrophy,\x20central\x20adiposity,\x20hyperlipidemia,\x20insulin\x20resistance,\x20and\x20nephrolithiasis.\x20Which\x20of\x20the\x20following\x20drugs\x20could\x20have\x20caused\x20these?','choices':[{'id':0x1,'text':_0x148940(0x37a)},{'id':0x2,'text':_0x148940(0x2db)},{'id':0x3,'text':'Ketoconazole'},{'id':0x4,'text':_0x148940(0x27f)}],'correct_choice_id':0x2,'solution':_0x148940(0x291),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20a\x20monoclonal\x20antibody\x20approved\x20for\x20use\x20in\x20the\x20treatment\x20of\x20HIV?','choices':[{'id':0x1,'text':_0x148940(0x2ed)},{'id':0x2,'text':_0x148940(0xde)},{'id':0x3,'text':_0x148940(0x391)},{'id':0x4,'text':'Pembrolizumab'}],'correct_choice_id':0x2,'solution':_0x148940(0x1db),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x148940(0x31d),'choices':[{'id':0x1,'text':_0x148940(0x196)},{'id':0x2,'text':_0x148940(0x23a)},{'id':0x3,'text':'Raltegravir'},{'id':0x4,'text':_0x148940(0x1d3)}],'correct_choice_id':0x3,'solution':_0x148940(0x143),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x148940(0x334);const quizFilename=_0x148940(0x2c5);let hierarchy=[_0x148940(0x182),_0x148940(0x300),_0x148940(0x2d5)];if(window[_0x148940(0x316)][_0x148940(0x16c)][_0x148940(0xec)](_0x148940(0x343))){const customData=JSON['parse'](localStorage[_0x148940(0xd7)](_0x148940(0x24a)));if(customData){const JCoJEl='5|1|0|3|2|4'['split']('|');let ruciBt=0x0;while(!![]){switch(JCoJEl[ruciBt++]){case'0':hierarchy=customData[_0x148940(0x1ba)];continue;case'1':quizName=customData[_0x148940(0xf6)];continue;case'2':document[_0x148940(0x1d5)](_0x148940(0x20a))['textContent']=questionsData[_0x148940(0x331)];continue;case'3':document[_0x148940(0x359)]=quizName+_0x148940(0x1d8);continue;case'4':document['getElementById'](_0x148940(0x11f))[_0x148940(0x1a7)]=hierarchy[_0x148940(0x253)](_0x148940(0x26e));continue;case'5':questionsData=customData[_0x148940(0x289)];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x148940(0xe2),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x148940(0x129)](),quizStartTime=Date[_0x148940(0x129)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x148940(0x331)])[_0x148940(0x22f)](null)[_0x148940(0x362)](()=>({'status':_0x148940(0x26d),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x148940(0x331)]};function saveProgress(){const _0x348641=_0x148940,_0x1c0f93={'eekml':'userHistory','FVAqV':'incomplete'};if(isQuizCompleted)return;const _0x5120f9=JSON[_0x348641(0x2e7)](localStorage[_0x348641(0xd7)](_0x1c0f93[_0x348641(0x116)]))||{};_0x5120f9[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x1c0f93[_0x348641(0x16b)],'lastSeen':new Date()[_0x348641(0x1fd)]()},localStorage[_0x348641(0x1dd)](_0x348641(0x371),JSON['stringify'](_0x5120f9));}function loadProgress(){const _0x54db92=_0x148940,_0x4a15dc={'RgBFF':'userHistory','hsImL':_0x54db92(0xf7)},_0x1760be=JSON[_0x54db92(0x2e7)](localStorage[_0x54db92(0xd7)](_0x4a15dc[_0x54db92(0x1cd)]))||{},_0xc7b4e7=_0x1760be[quizFilename];if(_0xc7b4e7){const _0x41894d=_0x54db92(0x238)[_0x54db92(0x18b)]('|');let _0x2920bc=0x0;while(!![]){switch(_0x41894d[_0x2920bc++]){case'0':currentQuestionIndex=_0xc7b4e7[_0x54db92(0x14d)];continue;case'1':return!![];case'2':currentMode=_0xc7b4e7[_0x54db92(0x29f)];continue;case'3':console[_0x54db92(0x329)](_0x4a15dc[_0x54db92(0x221)]);continue;case'4':stats=_0xc7b4e7[_0x54db92(0x2f7)];continue;case'5':questionStates=_0xc7b4e7[_0x54db92(0x21c)];continue;}break;}}return![];}function clearProgress(){const _0x36cec9=_0x148940,_0x2eb0a1={'rJKjU':function(_0x5207b8,_0x525885){return _0x5207b8===_0x525885;},'iCoMu':function(_0x213e42,_0x5264df){return _0x213e42===_0x5264df;},'twCvm':_0x36cec9(0x1bf),'QbDIM':_0x36cec9(0xff),'yDJbX':'userHistory','FZFgp':function(_0x2bbce9,_0x470cba){return _0x2bbce9!==_0x470cba;},'yoFXX':_0x36cec9(0x16a),'jZreK':_0x36cec9(0x16f),'THIni':_0x36cec9(0x383)},_0x1a820d=JSON[_0x36cec9(0x2e7)](localStorage[_0x36cec9(0xd7)](_0x2eb0a1[_0x36cec9(0x213)]))||{};if(_0x1a820d[quizFilename]){if(_0x2eb0a1[_0x36cec9(0x305)](_0x2eb0a1[_0x36cec9(0x2c7)],_0x2eb0a1[_0x36cec9(0x39c)]))delete _0x1a820d[quizFilename],localStorage[_0x36cec9(0x1dd)](_0x2eb0a1[_0x36cec9(0x213)],JSON[_0x36cec9(0x1a3)](_0x1a820d)),console[_0x36cec9(0x329)](_0x2eb0a1['THIni']);else{const _0x2c736d=_0x2eb0a1[_0x36cec9(0x22a)](_0xd29135[_0x36cec9(0x179)],_0x536668),_0x33bdb5=_0x2eb0a1[_0x36cec9(0x32d)](_0x21473e['id'],_0x56954c);let _0x8b1773=_0x2eb0a1[_0x36cec9(0x156)];if(_0x33bdb5)_0x8b1773=_0x2eb0a1['QbDIM'];else{if(_0x2c736d)_0x8b1773=_0x36cec9(0x2b7);}return _0x36cec9(0x120)+_0x8b1773+_0x36cec9(0x2d2)+_0x256cb5['fromCharCode'](0x41+_0x58904d)+_0x36cec9(0x124)+_0x4c43cc[_0x36cec9(0x320)]+_0x36cec9(0xd0);}}}function markQuizAsCompleted(){const _0x22bbd0=_0x148940,_0x4efd9f={'GihlU':_0x22bbd0(0x371),'sbOOT':_0x22bbd0(0x105)},_0x504ab3=JSON[_0x22bbd0(0x2e7)](localStorage[_0x22bbd0(0xd7)](_0x4efd9f[_0x22bbd0(0x12f)]))||{},_0x2219db=questionsData[_0x22bbd0(0x331)],_0x4ee940=stats[_0x22bbd0(0x2ca)]||0x0;_0x504ab3[quizFilename]={'score':_0x4ee940,'total':_0x2219db,'status':_0x4efd9f[_0x22bbd0(0x395)],'completedOn':new Date()[_0x22bbd0(0x1fd)]()},localStorage[_0x22bbd0(0x1dd)](_0x4efd9f[_0x22bbd0(0x12f)],JSON[_0x22bbd0(0x1a3)](_0x504ab3));}const urlParams=new URLSearchParams(window[_0x148940(0x316)][_0x148940(0x33c)]),startAt=parseInt(urlParams[_0x148940(0x299)](_0x148940(0x21e))),resume=urlParams['get'](_0x148940(0x28d))===_0x148940(0xe1);function goBack(){const _0x313662=_0x148940,_0x1a0ff6={'Magqo':_0x313662(0xf5)};if(!isQuizCompleted)saveProgress();window[_0x313662(0x316)]['href']=document[_0x313662(0x13c)]||_0x1a0ff6[_0x313662(0x262)];}function selectMode(_0x1f5241){const _0x477d7f=_0x148940,_0x5adf9f={'VHnmy':function(_0x19a29f){return _0x19a29f();}};currentMode=_0x1f5241,document['getElementById'](_0x477d7f(0x121))[_0x477d7f(0x373)][_0x477d7f(0x12d)]=_0x477d7f(0x24c),_0x5adf9f[_0x477d7f(0x21f)](initializeQuiz);}function initializeQuiz(){const _0x723b28=_0x148940,_0x754923={'tckcX':_0x723b28(0x264),'bgMvI':_0x723b28(0x2da),'cdssR':function(_0x39170c,_0x45c9ff){return _0x39170c===_0x45c9ff;},'peVpY':_0x723b28(0x37b),'rzswe':_0x723b28(0x288),'yGHjn':_0x723b28(0x31e),'lNACV':_0x723b28(0x243),'tAzZf':_0x723b28(0x24c),'PmOVw':_0x723b28(0x281),'shSHW':_0x723b28(0x292),'WAEep':_0x723b28(0x1d0),'UJMIR':function(_0x40dd40,_0x12a971){return _0x40dd40===_0x12a971;},'qQida':_0x723b28(0x107),'lQeIr':_0x723b28(0xd8),'YzCAD':function(_0x50a35d,_0x4dd8c3){return _0x50a35d(_0x4dd8c3);},'PDdti':function(_0x591f3d,_0x30a67d){return _0x591f3d>=_0x30a67d;},'spWUg':function(_0x280e17,_0x2a7e6f){return _0x280e17===_0x2a7e6f;},'OJomC':_0x723b28(0x308),'kNiMV':_0x723b28(0x1ea),'WCgmX':function(_0x5657a4){return _0x5657a4();},'HMNAQ':function(_0x16fdfa){return _0x16fdfa();},'UrYyH':function(_0xf41317){return _0xf41317();},'Idqbf':function(_0x282ed2){return _0x282ed2();}};quizStartTime=Date[_0x723b28(0x129)]();const _0x1c3ed9=document[_0x723b28(0x1d5)](_0x723b28(0x151)),_0xcc4226=document['getElementById'](_0x754923[_0x723b28(0x272)]),_0x177529=document[_0x723b28(0x1d5)](_0x754923[_0x723b28(0x2bd)]),_0x33947d=_0x754923['cdssR'](currentMode,_0x754923[_0x723b28(0x1b0)])||currentMode===_0x723b28(0x107);document[_0x723b28(0x1d5)](_0x754923[_0x723b28(0x20d)])[_0x723b28(0x373)][_0x723b28(0x12d)]=_0x33947d?_0x723b28(0x24c):_0x754923['yGHjn'],document[_0x723b28(0x1d5)](_0x754923[_0x723b28(0x1f2)])[_0x723b28(0x373)][_0x723b28(0x12d)]=_0x33947d?_0x754923[_0x723b28(0xef)]:_0x754923[_0x723b28(0x361)],document[_0x723b28(0x1d5)](_0x754923[_0x723b28(0xd3)])['style']['display']=_0x33947d?_0x723b28(0x31e):_0x754923[_0x723b28(0xef)],document[_0x723b28(0x1d5)](_0x754923[_0x723b28(0x245)])[_0x723b28(0x373)][_0x723b28(0x12d)]=_0x33947d?'block':_0x754923[_0x723b28(0xef)],_0x1c3ed9['style']['display']=_0x33947d?_0x754923[_0x723b28(0xef)]:_0x754923['WAEep'],_0xcc4226['style'][_0x723b28(0x12d)]=_0x33947d?'flex':'none',_0x177529['style']['display']=_0x33947d?_0x754923[_0x723b28(0xd6)]:_0x754923[_0x723b28(0xef)],(_0x754923['UJMIR'](currentMode,_0x723b28(0x1e6))||_0x754923[_0x723b28(0x367)](currentMode,_0x754923[_0x723b28(0x115)]))&&document['getElementById'](_0x754923['lQeIr'])['classList'][_0x723b28(0x389)](_0x723b28(0x1a2)),!_0x754923['YzCAD'](isNaN,startAt)&&_0x754923['PDdti'](startAt,0x0)&&startAt<questionsData[_0x723b28(0x331)]&&(_0x754923['spWUg'](_0x754923[_0x723b28(0x2be)],_0x754923[_0x723b28(0x353)])?_0x5b33bf[_0x723b28(0x211)]=_0x2de61d:currentQuestionIndex=startAt),_0x754923[_0x723b28(0x1b2)](loadBookmarkedQuestions),_0x754923['HMNAQ'](generateQuestionNav),_0x754923['UrYyH'](updateStats),_0x754923['Idqbf'](displayQuestion);}function generateQuestionNav(){const _0x34a9a4=_0x148940,_0x3e286c={'zCUcI':_0x34a9a4(0x2ad),'oiBlD':function(_0x3331e0,_0x58e60e){return _0x3331e0<_0x58e60e;},'QUjXI':_0x34a9a4(0x180),'CzHSC':function(_0x39e249,_0x1a5a65){return _0x39e249+_0x1a5a65;}},_0x45adbe=document[_0x34a9a4(0x1d5)](_0x3e286c[_0x34a9a4(0x315)]);_0x45adbe[_0x34a9a4(0x25a)]='';for(let _0x1da3d0=0x0;_0x3e286c[_0x34a9a4(0x1f8)](_0x1da3d0,questionsData[_0x34a9a4(0x331)]);_0x1da3d0++){const _0x4ce28f=document[_0x34a9a4(0x286)](_0x3e286c['QUjXI']);_0x4ce28f[_0x34a9a4(0x1a7)]=_0x3e286c[_0x34a9a4(0x230)](_0x1da3d0,0x1),_0x4ce28f[_0x34a9a4(0x36c)]=_0x34a9a4(0x38f),_0x4ce28f['onclick']=()=>jumpToQuestion(_0x1da3d0),_0x4ce28f['id']=_0x34a9a4(0x32b)+_0x1da3d0,_0x45adbe[_0x34a9a4(0x1f5)](_0x4ce28f);}updateQuestionNav();}function updateQuestionNav(){const _0x182cfc=_0x148940,_0x18cb60={'UxIaJ':function(_0x241e21){return _0x241e21();},'VsaiD':'Correct','xRXfP':function(_0x5800ae,_0x30b9f1){return _0x5800ae(_0x30b9f1);},'uSlGz':function(_0x27709f,_0x5ba538){return _0x27709f+_0x5ba538;},'mXDyE':_0x182cfc(0xd5),'KOMCc':_0x182cfc(0x10b),'NQhYt':function(_0x1d34cd){return _0x1d34cd();},'jBzpH':_0x182cfc(0x329),'RActp':_0x182cfc(0x20c),'YEgOl':'info','OIEzo':'error','jdsCZ':_0x182cfc(0x22c),'OQfZn':'table','zhirF':_0x182cfc(0x261),'vTBGX':function(_0x3901c6,_0x3854d){return _0x3901c6<_0x3854d;},'rQzGI':function(_0x1b7220,_0x5dc01a){return _0x1b7220===_0x5dc01a;},'nVuVF':function(_0x4123ae,_0x2615bc){return _0x4123ae!==_0x2615bc;},'vdoPV':_0x182cfc(0x168),'RjIrc':_0x182cfc(0x1be),'LgFOd':'nav-btn-bookmarked','qjicP':function(_0xca5219,_0x325e44){return _0xca5219!==_0x325e44;},'IBLqt':_0x182cfc(0x2c9),'NdlLg':_0x182cfc(0x148),'jvpRJ':function(_0x11ea0b,_0x300f14){return _0x11ea0b===_0x300f14;},'sMYuo':_0x182cfc(0xe2),'oYXrQ':function(_0x3431db,_0xbb602c){return _0x3431db===_0xbb602c;},'MnVTi':_0x182cfc(0x1e6),'lFusO':_0x182cfc(0x23b),'JQfTV':_0x182cfc(0x198),'HxsUU':_0x182cfc(0x1c1),'kBwhd':_0x182cfc(0x2b5),'typSZ':function(_0x17564d,_0x5370e4){return _0x17564d===_0x5370e4;},'uHgBI':_0x182cfc(0x318),'kIdMY':_0x182cfc(0x17c),'HBuDS':_0x182cfc(0x330),'rQQoP':function(_0x519b24,_0x11d4d3){return _0x519b24!==_0x11d4d3;},'jYtuT':_0x182cfc(0x32f),'RHdRp':'nav-btn-answered'};for(let _0x57c7c2=0x0;_0x57c7c2<questionsData[_0x182cfc(0x331)];_0x57c7c2++){const _0x53df02=document[_0x182cfc(0x1d5)](_0x182cfc(0x32b)+_0x57c7c2),_0x429444=questionStates[_0x57c7c2];let _0x39878f='';if(_0x18cb60[_0x182cfc(0x2c6)](_0x57c7c2,currentQuestionIndex))_0x18cb60['nVuVF'](_0x18cb60[_0x182cfc(0x25d)],_0x18cb60[_0x182cfc(0x325)])?_0x39878f=_0x182cfc(0x378):_0x389418=_0x1627bf[_0x182cfc(0xda)](_0x396c3b=>!(_0x396c3b[_0x182cfc(0x28f)][_0x182cfc(0x1a8)](_0x3bec51[_0x182cfc(0x101)]()[_0x182cfc(0x11d)](/ /g,'-'))&&_0x396c3b[_0x182cfc(0x1ff)]===_0x23486f));else{if(_0x429444[_0x182cfc(0x252)])_0x39878f=_0x18cb60[_0x182cfc(0x278)];else{if(_0x429444[_0x182cfc(0x1ab)])_0x18cb60['qjicP'](_0x18cb60['IBLqt'],_0x18cb60[_0x182cfc(0x13f)])?(_0x2d4603=0x0,_0x18cb60[_0x182cfc(0x220)](_0x4c3e3a),_0x18cb60[_0x182cfc(0x220)](_0x1da80b)):_0x39878f=_0x18cb60['NdlLg'];else{if(_0x18cb60['jvpRJ'](currentMode,_0x18cb60['sMYuo'])||_0x18cb60[_0x182cfc(0x24b)](currentMode,_0x18cb60[_0x182cfc(0x319)])){if(_0x18cb60[_0x182cfc(0x2c6)](_0x18cb60['lFusO'],_0x18cb60[_0x182cfc(0x21a)]))_0x159c6e=_0x182cfc(0x1c1),_0x573ad7=_0x18cb60[_0x182cfc(0x2c1)];else{if(_0x18cb60['oYXrQ'](_0x429444[_0x182cfc(0x1e9)],_0x18cb60[_0x182cfc(0x10e)]))_0x39878f=_0x18cb60[_0x182cfc(0xfd)];else{if(_0x18cb60['typSZ'](_0x429444[_0x182cfc(0x1e9)],_0x18cb60[_0x182cfc(0x342)]))_0x39878f=_0x18cb60['kIdMY'];else _0x39878f=_0x18cb60[_0x182cfc(0x1ef)];}}}else{if(_0x18cb60[_0x182cfc(0x30b)](_0x18cb60[_0x182cfc(0x32e)],_0x18cb60['jYtuT'])){let _0xf5c8f;try{const _0x33121a=tfYJFJ[_0x182cfc(0x210)](_0x16efcf,tfYJFJ[_0x182cfc(0x332)](tfYJFJ[_0x182cfc(0x332)](tfYJFJ[_0x182cfc(0x21d)],tfYJFJ[_0x182cfc(0xd2)]),');'));_0xf5c8f=tfYJFJ['NQhYt'](_0x33121a);}catch(_0x141b83){_0xf5c8f=_0x4d9b03;}const _0x54cf30=_0xf5c8f['console']=_0xf5c8f[_0x182cfc(0x1bb)]||{},_0x27a4f1=[tfYJFJ[_0x182cfc(0x346)],tfYJFJ[_0x182cfc(0x399)],tfYJFJ[_0x182cfc(0x369)],tfYJFJ[_0x182cfc(0x25c)],tfYJFJ[_0x182cfc(0x159)],tfYJFJ[_0x182cfc(0x27d)],tfYJFJ[_0x182cfc(0x312)]];for(let _0xe570ad=0x0;tfYJFJ[_0x182cfc(0x266)](_0xe570ad,_0x27a4f1[_0x182cfc(0x331)]);_0xe570ad++){const _0x57a010=_0x5e254b[_0x182cfc(0x2d4)][_0x182cfc(0x14a)][_0x182cfc(0xe9)](_0x4ae627),_0x80e858=_0x27a4f1[_0xe570ad],_0x14b00a=_0x54cf30[_0x80e858]||_0x57a010;_0x57a010[_0x182cfc(0x194)]=_0x1e8257[_0x182cfc(0xe9)](_0x508a2f),_0x57a010['toString']=_0x14b00a[_0x182cfc(0x28c)][_0x182cfc(0xe9)](_0x14b00a),_0x54cf30[_0x80e858]=_0x57a010;}}else{if(_0x429444['selectedAnswer']!==null)_0x39878f=_0x18cb60[_0x182cfc(0x1ec)];else _0x39878f=_0x18cb60[_0x182cfc(0x1ef)];}}}}}_0x53df02[_0x182cfc(0x36c)]=_0x182cfc(0x2a5)+_0x39878f;}}function _0x582e(){const _0x3701f2=['KWUXN','Which\x20of\x20the\x20following\x20is\x20an\x20integrase\x20inhibitor\x20indicated\x20in\x20the\x20treatment\x20of\x20patients\x20with\x20HIV?','block','VjuSa','text','strokeDasharray','It\x20is\x20an\x20effective\x20agent\x20for\x20\x20patients\x20with\x20chronic\x20hepatitis\x20B','<p>The\x20given\x20clinical\x20scenario\x20depicts\x20a\x20case\x20of\x20<strong>orthostatic\x20hypotension</strong>\x20and\x20<strong>maraviroc</strong>\x20is\x20associated\x20with\x20<strong>dose-dependent</strong>\x20and\x20<strong>concentration-dependent</strong>\x20orthostatic\x20hypotension.</p>\x0a<p>Maraviroc\x20is\x20a\x20chemokine\x20receptor\x20antagonist\x20acting\x20against\x20the\x20<strong>CCR5\x20receptor</strong>.\x20It\x20binds\x20to\x20the\x20host\x20cell\x20CCR-5\x20receptor\x20and\x20prevents\x20the\x20binding\x20of\x20viral\x20GP-120\x20to\x20host\x20cells.\x20It\x20is\x20indicated\x20in\x20patients\x20with\x20evidence\x20of\x20infection\x20with\x20predominantly\x20CCR-5\x20tropic\x20virus.</p>','bookmarkedQuestions','RjIrc','<p><strong>Maraviroc</strong>\x20is\x20a<strong>\x20chemokine\x20receptor\x20antagonist\x20</strong>acting\x20against\x20the\x20<strong>CCR5\x20receptor</strong>.</p>\x0a<p>It&nbsp;binds\x20to\x20the\x20host\x20cell\x20CCR-5\x20receptor\x20and\x20prevents\x20the\x20binding\x20of\x20viral\x20GP-120\x20to\x20host\x20cells.\x20It\x20is\x20indicated\x20in\x20patients\x20with\x20evidence\x20of\x20infection\x20with\x20predominantly\x20CCR-5\x20tropic\x20virus.</p>','notAttempted','Protease\x20inhibitors','log','XJteq','navBtn_','qcmwh','iCoMu','jYtuT','Wkxuh','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','length','uSlGz','Indinavir\x20can\x20cause\x20nephrolithiasis\x20when\x20adequate\x20hydration\x20is\x20not\x20maintained.','35\x20Antiretroviral\x20Drugs','PjDlP','HEitr','<p>The\x20drug\x20described\x20in\x20this\x20case\x20is\x20<strong>enfuvirtide</strong>,\x20which<strong>&nbsp;</strong>is\x20an\x20anti-HIV\x20drug\x20that\x20is\x20<strong>administered\x20subcutaneously.</strong></p>\x0a<p\x20class=\x22p1\x22>It\x20is\x20used\x20only\x20in\x20the\x20treatment\x20of\x20those\x20who\x20have\x20evidence\x20of\x20HIV\x20replication\x20(high\x20viral\x20load)\x20despite\x20ongoing\x20antiretroviral\x20therapy.</p>\x0a<p\x20class=\x22p1\x22>It\x20<strong>binds\x20to&nbsp;the\x20gp41\x20subunit</strong>\x20of\x20the\x20viral\x20envelope\x20and\x20<strong>prevents\x20the\x20fusion\x20</strong>of\x20the\x20virus\x20to\x20the\x20cellular\x20membranes\x20thereby\x20preventing\x20entry\x20of\x20the\x20virus.</p>\x0a<p\x20class=\x22p1\x22>Enfuvirtide\x20is\x20active\x20against<strong>\x20HIV-1\x20only</strong>.</p>','Mutations\x20of\x20reverse\x20transcriptase','Lactic\x20acidosis','rXviF','sSSmc','search','<p>The<strong>\x20maximum\x20risk\x20</strong>of<strong>\x20pancreatitis\x20</strong>is\x20seen\x20with\x20<strong>didanosine.\x20</strong></p>\x0a<p>It&nbsp;should,\x20therefore\x20not\x20be\x20combined\x20with\x20hydroxyurea,\x20alcohol,\x20or\x20pentamidine.</p>','kAfSa','questionMedia','eVfye','Saquinavir','uHgBI','custom_quiz.html','caIlE','onclick','jBzpH','solution','yEREZ','YPcmt','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','LfnAg','Which\x20is\x20the\x20only\x20antiretroviral\x20drug\x20that\x20may\x20have\x20teratogenic\x20properties?','GeXJE','explanation_audio_eng','correct_choice_id','rbGJm','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','Decreased\x20zidovudine\x20triphosphate\x20formation','kNiMV','yoEuM','wvxGS','kYriM','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','explanationVideoPlayer','title','TIMFf','No\x20solution\x20provided','padStart','gJnNQ','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','nxaxg','choices','yGHjn','map','csYAh','LobuO','<p>The\x20given\x20scenario\x20describes\x20<strong>psychiatric</strong>\x20or<strong>\x20CNS\x20adverse\x20effects</strong>,\x20which\x20are\x20commonly\x20seen\x20with\x20<strong>efavirenz</strong>.</p>\x0a<p>The\x20CNS/\x20<strong>psychiatric\x20adverse\x20effects</strong>\x20seen\x20with\x20the\x20use\x20of\x20<strong>efavirenz</strong>\x20are:</p>\x0a<ul>\x0a<li>Frank\x20psychosis\x20(depression,\x20hallucinations,\x20and/or\x20mania)&nbsp;</li>\x0a<li>Impaired\x20concentration</li>\x0a<li>Dysphoria&nbsp;</li>\x0a<li>Dizziness</li>\x0a<li>Vivid\x20dreams</li>\x0a<li>Insomnia</li>\x0a</ul>','nCEHa','cdssR','answered','YEgOl','vsndJ','Nucleotide\x20reverse\x20transcriptase\x20inhibitors','className','DzlsV','90axSqrF','Darunavir','iqgwD','userHistory','mAIWn','style','Emtricitabine','JTmSP','<p><strong>Efavirenz</strong>\x20is\x20not\x20indicated\x20for\x20HIV-2\x20infection.\x20It\x20is\x20a\x20non-nucleoside\x20reverse\x20transcriptase\x20inhibitor\x20(NNRTI).</p>\x0a<p>NNRTIs\x20are\x20HIV-1\x20specific\x20and\x20have\x20no\x20activity\x20against\x20HIV-2.\x20The\x20binding\x20site\x20for\x20<strong>NNRTI</strong>\x20is\x20virus\x20<strong>strain-specific</strong>\x20which\x20only\x20<strong>inhibits</strong>\x20the\x20<strong>HIV-1\x20reverse\x20transcriptase.</strong>\x20It\x20is\x20<strong>approved\x20only</strong>\x20for<strong>\x20HIV-1\x20infections</strong>\x20and\x20should\x20not\x20be\x20used\x20for\x20HIV-2\x20infections.</p>\x0a<p>Ritonavir,\x20tenofovir,\x20and\x20zalcitabine\x20are\x20indicated\x20for\x20HIV-2\x20infections.</p>','BJipE','nav-btn-current','<p>The\x20scenario\x20is\x20suggestive\x20of\x20peripheral\x20neuropathy.\x20The\x20drug\x20causing<strong>\x20maximum\x20peripheral\x20neuropathy\x20</strong>is<strong>\x20stavudine.</strong></p>\x0a<p>The\x20incidence\x20of\x20peripheral\x20neuropathy\x20is\x20very\x20rare\x20with\x20both\x20zidovudine\x20and\x20lamivudine.\x20<strong>Lamivudine</strong>&nbsp;is\x20considered\x20one\x20of\x20the<strong>&nbsp;least\x20toxic</strong>\x20antiretroviral\x20agents.</p>\x0a<p>Didanosine\x20is\x20frequently\x20associated\x20with\x20peripheral\x20neuropathy,\x20but\x20stavudine\x20is\x20associated\x20with\x20the\x20highest\x20risk\x20of\x20peripheral\x20neuropathy.</p>\x0a<p>Note:<strong>\x20Zalcitabine&nbsp;</strong>was&nbsp;associated\x20with\x20a&nbsp;<strong>higher\x20incidence&nbsp;</strong>of\x20peripheral\x20neuropathy.\x20It&nbsp;is\x20no\x20longer\x20marketed.</p>','Azidothymidine','test','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','tqhEH','bZenp','timeSpent','baUxo','pfyZw','hzABG','Previous\x20progress\x20cleared.','CHjSW','div','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','.m3u8','kULVO','remove','ggZwj','tirln','tpGBi','qxYoA','removeItem','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','IOFwG','Panitumumab','gray','3\x20and\x205','cHZgS','sbOOT','dqTiC','reload','DPjPL','RActp','dataset','LsUDf','jZreK','Tipranavir\x20is\x20used\x20in\x20sub-therapeutic\x20doses\x20as\x20a\x20pharmacodynamic\x20booster\x20in\x20cART.','OegSO','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','<div\x20class=\x22mt-4\x22><img\x20src=\x22','SkueU','</span></div>','HNaUh','KOMCc','PmOVw','jRtXe','return\x20(function()\x20','WAEep','getItem','timerContainer','BnzTs','filter','isSupported','Which\x20of\x20the\x20following\x20is\x20a\x20subcutaneously\x20administered\x20drug,\x20that\x20will\x20be\x20helpful\x20in\x20a\x20patient\x20showing\x20high\x20viral\x20load\x20despite\x20good\x20compliance\x20with\x20ART?','<p><strong>Lamivudine</strong>\x20and\x20<strong>emtricitabine</strong>\x20are\x20<strong>not\x20combined</strong>\x20because\x20of\x20similar\x20actions\x20and\x20<strong>no\x20added\x20benefits.</strong>\x20Emtricitabine\x20is\x20a\x20cytidine\x20analog.\x20It\x20is\x20chemically\x20related\x20to\x20lamivudine\x20and\x20shares\x20most\x20of\x20its\x20pharmacodynamic\x20characteristics.</p>\x0a<p>The\x20same\x20holds\x20good\x20for\x20the\x20<strong>zidovudine\x20and\x20stavudine</strong>\x20combination.\x20Zidovudine\x20and\x20stavudine\x20are\x20thymidine\x20analogues.\x20In\x20fact,\x20efficacy\x20may\x20even\x20decrease\x20because\x20of\x20competition\x20for\x20a\x20similar\x20activation\x20process.</p>','Ibalizumab','lFeQN','performanceModal','true','study','quizPerformanceData','The\x20antiviral\x20drug\x20having\x20dual\x20antiviral\x20activity\x20against\x20HIV\x20and\x20HBV\x20is:','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','qOaah','wLPwn','CCR5','bind','YZIOO','KmFQo','endsWith','obRid','lwPIS','tAzZf','HqPMS','strokeDashoffset','Non-nucleoside\x20reverse\x20transcriptase\x20inhibitors','fzrei','RyPee','index.html','name','Progress\x20loaded.','Not\x20Attempted','HsYBY','iFiRH','vjpur','apply','kBwhd','sSlLB','border-green-500','question_images','toLowerCase','A\x20patient\x20diagnosed\x20with\x20AIDS\x20is\x20planned\x20to\x20be\x20started\x20on\x20a\x20lamivudine-based-antiretroviral\x20therapy.\x20Which\x20of\x20the\x20following\x20drugs\x20will\x20you\x20not\x20add\x20to\x20her\x20regimen?','explanation_audio_hin','target','completed','ERJFx','timed_exam','nwsbP','MOAuA','NRaKS','{}.constructor(\x22return\x20this\x22)(\x20)','yfxqJ','Hfsjk','HxsUU','floor','FaEgr','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','gNIXh','Which\x20of\x20the\x20following\x20statements\x20about\x20lamivudine\x20is\x20false?','question_video','qQida','eekml','425970PMCIIm','During\x20a\x20clinical\x20trial,\x20it\x20was\x20noted\x20that\x20the\x20bioavailability\x20of\x20some\x20drugs\x20was\x20substantially\x20improved\x20on\x20ritonavir\x20administration.\x20Which\x20of\x20the\x20following\x20drugs\x20does\x20not\x20exhibit\x20this\x20property?','LcVRY','lJzLg','YPSQE','pop','replace','<p><strong>Resistance</strong>\x20to\x20<strong>zidovudine</strong>\x20occurs\x20due\x20to\x20<strong>mutations</strong>\x20in\x20the<strong>\x20reverse\x20transcriptase\x20enzyme.</strong></p>\x0a<p>The\x20mutations\x20are\x20referred\x20to\x20as\x20<strong>thymidine\x20analog\x20mutations</strong>\x20(TAM)\x20because\x20of\x20their\x20ability\x20to\x20confer\x20<strong>cross-resistance</strong>\x20to\x20other\x20thymidine\x20analogs\x20such\x20as\x20stavudine.</p>\x0a<p><strong>M184V\x20mutation,</strong>\x20which\x20is\x20associated\x20with\x20the\x20use\x20of\x20lamivudine\x20or\x20emtricitabine,\x20<strong>restores\x20zidovudine\x20susceptibility</strong>\x20in\x20zidovudine-resistant\x20HIV.</p>','quizHierarchy','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','modeModal','MMIqS','HDVXT','</span><span>','bILxU','TIfah','EOZOi','Tenofovir','now','https://cdn1.dailyrounds.org/uploads/ef1e9f9f002544b5a2a453e8aa910ce3.JPEG','Enfuvirtide','KNHee','display','1\x20and\x203','GihlU','stlYg','progressBar','WcGko','hVEuw','\x22\x20data-src=\x22','Zidovudine','Etravirine','356262EMlVRJ','A\x20patient\x20on\x20antiretroviral\x20therapy\x20presents\x20with\x20severe\x20tingling\x20and\x20numbness\x20in\x20the\x20legs.\x20On\x20examination,\x20you\x20find\x20that\x20his\x20tendon\x20reflexes\x20are\x20reduced.\x20Which\x20of\x20the\x20following\x20drugs\x20has\x20the\x20highest\x20propensity\x20to\x20cause\x20this\x20condition?','Bookmark','IZuyW','ExIVU','referrer','INpoZ','No\x20question\x20text\x20available','IBLqt','JPQUv','MVFzR','Stavudine','<div\x20class=\x22p-rich_text_section\x22>\x0a<p>The<strong><span\x20data-preserver-spaces=\x22true\x22>\x20integrase\x20inhibitor</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;indicated\x20in\x20the\x20treatment\x20of\x20HIV\x20is&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>raltegravir</span></strong><span\x20data-preserver-spaces=\x22true\x22>.\x20</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>It\x20inhibits\x20the\x20catalytic\x20activity\x20of\x20the\x20HIV-encoded\x20integrase\x20and&nbsp;</span><strong>prevents</strong>\x20the\x20<strong>integration</strong>\x20of\x20<strong>virus\x20DNA</strong>\x20in<strong>to</strong>\x20the\x20<strong>host\x20chromosome</strong><span\x20data-preserver-spaces=\x22true\x22><strong>.</strong>\x20It\x20is\x20eliminated\x20primarily\x20by\x20glucuronidation\x20by\x20UGT1A1.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>The\x20other\x20two\x20FDA-approved\x20integrase\x20inhibitors\x20are&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>elvitegravir</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;(EVG)\x20and&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>dolutegravir</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;(DTG).</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Options\x20A\x20and\x20D:\x20Lopinavir\x20and\x20ritonavir\x20are\x20protease\x20inhibitors.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Option\x20B:\x20Abacavir\x20is\x20a\x20nucleoside\x20reverse\x20transcriptase\x20inhibitor.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Note:&nbsp;&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>Dolutegravir&nbsp;</span></strong><span\x20data-preserver-spaces=\x22true\x22>(DTG)\x20is\x20recommended\x20as\x20the\x20preferred\x20third\x20drug\x20for\x20HIV\x20post-exposure\x20prophylaxis\x20as\x20per\x20the\x20recent\x20MOHFW\x20Jan\x202020\x20guideline,\x20in\x20line\x20with\x20WHO.</span></p>\x0a<p><span\x20data-sheets-value=\x22{&quot;1&quot;:2,&quot;2&quot;:&quot;The\x20FDA\x20approved\x20Dolutegravir\x20tablets\x20and\x20suspension\x20to\x20treat\x20HIV-1\x20infection\x20in\x20pediatric\x20patients\x20at\x20least\x20four\x20weeks\x20old\x20and\x20weighing\x20at\x20least\x203\x20kg\x20who\x20have\x20never\x20been\x20treated\x20for\x20HIV\x20or\x20who\x20have\x20been\x20treated,\x20but\x20not\x20with\x20an\x20integrase\x20inhibitor\x20class\x20of\x20drug.&quot;}\x22\x20data-sheets-userformat=\x22{&quot;2&quot;:895,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0}\x22>The\x20FDA\x20approved\x20dolutegravir\x20tablets\x20and\x20suspension\x20for\x20the\x20treatment\x20of\x20HIV-1\x20infection\x20in\x20pediatric\x20patients\x20at\x20least\x20four\x20weeks\x20old\x20and\x20weighing\x20at\x20least\x203\x20kg\x20who\x20have\x20never\x20been\x20treated\x20for\x20HIV\x20or\x20who\x20have\x20been\x20treated,\x20but\x20not\x20with\x20an\x20integrase\x20inhibitor\x20class\x20of\x20drug.</span></p>\x0a<p><span\x20data-sheets-value=\x22{&quot;1&quot;:2,&quot;2&quot;:&quot;The\x20FDA\x20approved\x20Dolutegravir\x20tablets\x20and\x20suspension\x20to\x20treat\x20HIV-1\x20infection\x20in\x20pediatric\x20patients\x20at\x20least\x20four\x20weeks\x20old\x20and\x20weighing\x20at\x20least\x203\x20kg\x20who\x20have\x20never\x20been\x20treated\x20for\x20HIV\x20or\x20who\x20have\x20been\x20treated,\x20but\x20not\x20with\x20an\x20integrase\x20inhibitor\x20class\x20of\x20drug.&quot;}\x22\x20data-sheets-userformat=\x22{&quot;2&quot;:895,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0}\x22>WHO\x20recently\x20recommended<strong>\x20long-acting\x20Cabotegravir</strong>,\x20an\x20HIV\x20integrase\x20strand\x20transfer\x20inhibitor\x20may\x20be\x20offered\x20as\x20a\x20<strong>HIV\x20prevention</strong>\x20option\x20for\x20people\x20at\x20substantial\x20risk\x20of\x20HIV\x20infection.\x20It\x20is\x20an\x20<strong>IM\x20injectable</strong>\x20form\x20of\x20<strong>pre-exposure\x20prophylaxis</strong>\x20that\x20has\x20been\x20shown\x20to\x20be\x20highly\x20effective\x20at\x20reducing\x20the\x20risk\x20of\x20HIV\x20acquisition.\x20The\x20first<strong>\x202\x20injections</strong>\x20were\x20administered\x20<strong>4\x20weeks\x20apart</strong>,\x20followed\x20thereafter\x20by\x20an\x20<strong>injection\x20every\x208\x20weeks</strong>.</span>&nbsp;</p>\x0a</div>','RKpYQ','hhdNO','classList','VJkNk','nav-btn-marked-review','FyqkW','prototype','rkSht','quizSidebar','currentQuestionIndex','lUEmF','Atazanavir\x20has\x20the\x20lowest\x20propensity\x20to\x20increase\x20total\x20cholesterol\x20levels.','wzFoE','bookmarkBtn','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','toggle','AZTvI','afnPN','twCvm','uZYru','fmXlE','jdsCZ','8581551aeEzTM','Jgcoy','notAttemptedResult','NzcfG','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','VHdXU','rWRMG','Buvxy','Ritonavir\x20is\x20a\x20potent\x20inhibitor\x20of\x20the\x20CYP3A4\x20isoform\x20of\x20P450\x20&\x20may\x20alter\x20levels\x20of\x20drugs.','<p>The\x20image\x20shows\x20<strong>nail\x20hyperpigmentation</strong>\x20and\x20it\x20is\x20commonly\x20encountered\x20with\x20the\x20use\x20of\x20zidovudine.\x20This\x20is\x20seen\x20with\x20<strong>c</strong><strong>hronic\x20zidovudine\x20administration.&nbsp;</strong></p>\x0a<p>The\x20<strong>adverse\x20effects</strong>\x20of\x20<strong>zidovudine</strong>\x20are:</p>\x0a<ul>\x0a<li>Fatigue,\x20malaise,\x20myalgia,\x20and\x20anorexia</li>\x0a<li>Headache\x20and\x20insomnia</li>\x0a<li>Erythrocytic\x20macrocytosis</li>\x0a<li>Nail\x20hyperpigmentation</li>\x0a<li>Myopathy</li>\x0a<li>Bone\x20marrow\x20suppression\x20-\x20anemia\x20and\x20granulocytopenia</li>\x0a</ul>','(((.+)+)+)+$','2696645nIXJPU','keXrC','WelPk','pZDPE','kKzLU','oHPrO','FVAqV','pathname','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','1\x20and\x205','NSAhv','VokXh','Cobicistat','rLqsW','gAUsW','iCVZZ','cjQla','XENwD','review-question\x20','jYJLE','selectedAnswer','BVgZd','FAKPw','nav-btn-incorrect','BpHjB','<p>The\x20given\x20ECG\x20indicates\x20<strong>QT\x20interval\x20prolongation</strong>\x20(normal\x20QTc\x20=\x20440ms)\x20and\x20this\x20is\x20observed\x20with\x20the\x20use\x20of\x20<strong>rilpivirine.\x20</strong>It\x20is\x20a\x20non-nucleoside\x20reverse\x20transcriptase\x20inhibitor\x20(<strong>NNRTI</strong>).<strong>&nbsp;</strong></p>\x0a<p>Qtc\x20interval\x20prolongation\x20is\x20observed\x20with\x20higher\x20concentrations\x20of\x20the\x20drug.\x20Caution\x20has\x20to\x20be\x20exercised\x20when\x20rilpivirine\x20is\x20administered\x20along\x20with\x20<strong>CYP3A4\x20inhibitors</strong>\x20that\x20can<strong>\x20increase</strong>\x20the<strong>\x20concentration\x20</strong>of\x20rilpivirine.</p>','accuracy','button','contains','Marrow','lBmQK','incorrectAnswers','vpYrG','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Jjszv','RURGg','xRkUw','bGxNl','split','kQRud','tVPtr','ARIEf','vKSOw','Efavirenz','PNMdz','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','NWrjg','__proto__','cjqSX','Lopinavir','IcFfI','LHjAR','amqWl','SpyzC','dEbwJ','JkTpa','xZcgK','214410LIhjAB','data-option-index','lbmAx','Gmtce','hidden','stringify','HKOtu','phZut','ArrowLeft','textContent','includes','reviewQuestionsContainer','frept','markedForReview','lVBov','YREkn','36zIPoTa','ITeBm','peVpY','Marked','WCgmX','Increased\x20efflux\x20of\x20the\x20drug\x20from\x20nucleus','wmDvY','ddpBB','tULUF','reduce','vklfP','jjLCC','hierarchy','console','DOMContentLoaded','forEach','DHBzM','border-gray-600','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','correct','UgelD','rdLPZ','uGecE','NmdRW','39532iXArSD','Nevirapine','XImHi','Which\x20of\x20the\x20following\x20drugs\x20are\x20not\x20protease\x20inhibitors?','OEUtY','selected','HGoob','RgBFF','2\x20and\x204','totalTime','flex','fxNGt','gpBVF','Ritonavir','46zQbDRR','getElementById','YuSxY','avgTimeResult','\x20-\x20Brain\x20And\x20Scalpel','qJOSU','urtwU','<p\x20class=\x22p1\x22><strong>Ibalizumab</strong>\x20is\x20an\x20<strong>anti-CD4\x20monoclonal\x20antibody</strong>\x20approved\x20for\x20use\x20in\x20the\x20treatment\x20of&nbsp;<strong>multidrug-resistant\x20HIV-1.&nbsp;</strong>It\x20is\x20administered\x20<strong>intravenously.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20acts\x20as\x20an\x20entry\x20inhibitor.\x20It\x20blocks\x20HIV-1\x20from\x20infecting\x20CD4+\x20T\x20cells\x20by\x20binding\x20to\x20domain\x202\x20of\x20CD4\x20cells.\x20It\x20also\x20interferes\x20with\x20post-attachment\x20steps\x20required\x20for\x20the\x20entry\x20of\x20HIV-1\x20virus\x20particles\x20into\x20host\x20cells\x20and\x20thus\x20prevents\x20the\x20viral\x20transmission\x20that\x20occurs\x20via\x20cell-cell\x20fusion.</p>','Nucleoside\x20reverse\x20transcriptase\x20inhibitors','setItem','<p>The\x20<strong>daily\x20dose</strong>&nbsp;of\x20lamivudine\x20indicated\x20for\x20<strong>HIV\x20(300\x20mg)\x20</strong>is<strong>\x20higher\x20than\x20</strong>that\x20of\x20the\x20dose\x20indicated\x20for<strong>\x20HBV\x20(100\x20mg).</strong></p>\x0a<p>Lamivudine\x20has\x20<strong>both\x20anti-HIV</strong>\x20and\x20<strong>anti-HBV</strong>\x20activity\x20and\x20is\x20an\x20<strong>effective</strong>\x20agent\x20for\x20patients\x20with\x20<strong>chronic\x20hepatitis</strong>\x20<strong>B</strong>.\x20It\x20should\x20not\x20be\x20used\x20alone\x20because\x20resistance\x20can\x20rapidly\x20emerge\x20in\x20HIV\x20viruses.</p>\x0a<p>Anti-HBe\x20seroconversion\x20occurs\x20in\x20only\x20a\x20minority\x20of\x20the\x20patients\x20taking\x20lamivudine.</p>\x0a<p>Drugs\x20that\x20cause\x20anti-HBe\x20seroconversion:</p>\x0a<ul>\x0a<li>Lamivudine</li>\x0a<li>Entecavir</li>\x0a<li>Adefovir</li>\x0a<li>Tenofovir</li>\x0a<li>Telbivudine</li>\x0a<li>Pegylated\x20interferon</li>\x0a</ul>','gYXBU','qqHaf','Peripheral\x20neuropathy','disabled','jHNQh','dmOeU','VcMhl','timed_study','usswQ','closest','status','GQZiT','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','RHdRp','correctResult','WeHJs','HBuDS','mYZSc','add','lNACV','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','appendChild','oBXdN','YMGMV','oiBlD','Correct','TJhpK','MNRgC','EFJoK','toISOString','round','questionIndex','hXckD','querySelectorAll','2008HqHsti','qqqls','keydown','ShSzD','dnCGu','PqFPf','nBWpR','<p><strong>Cobicistat</strong>\x20is\x20a\x20pharmacological\x20booster\x20with\x20<strong>no\x20antiretroviral\x20activity</strong>.</p>\x0a<p>Cobicistat\x20is\x20a\x20<strong>ritonavir\x20analog</strong>\x20developed\x20as\x20an\x20exclusive\x20<strong>pharmacological\x20booster</strong>\x20that\x20<strong>inhibits</strong>\x20the<strong>\x20CYP3A4\x20enzyme</strong>\x20and\x20has\x20no\x20antiviral\x20activity.\x20It\x20is&nbsp;available\x20only\x20in\x20combination\x20with\x20atazanavir\x20or\x20darunavir\x20or\x20elvitegravir\x20for\x20HIV\x20infections.</p>\x0a<p>Ritonavir\x20is\x20also\x20used\x20as\x20a\x20pharmacological\x20booster\x20but\x20it\x20has\x20antiretroviral\x20activity.</p>\x0a<table\x20style=\x22height:\x20174px;\x22\x20width=\x22543\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20263.5px;\x20text-align:\x20center;\x22><strong>Cobicistat</strong></td>\x0a<td\x20style=\x22width:\x20263.5px;\x20text-align:\x20center;\x22><strong>Ritonavir</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Specific\x20CYP3A4\x20inhibition</td>\x0a<td\x20style=\x22width:\x20263.5px;\x22>\x0a<p>Potent\x20inhibitor\x20of\x20CYP3A4\x20and\x20weak\x20inhibitor\x20of\x20CYP2D6</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Better\x20tolerated</td>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Less\x20tolerated&nbsp;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Reduced\x20impact\x20on\x20plasma\x20lipds</td>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Causes\x20dose-dependent\x20elevation\x20in\x20serum\x20total\x20cholesterol\x20and\x20<br\x20/>triglycerides</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Lacks\x20P450\x20enzyme\x20induction</td>\x0a<td\x20style=\x22width:\x20263.5px;\x22>Moderate\x20inducer\x20of\x20P450\x20enzymes</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>&nbsp;Vorinostat\x20and\x20belinostat\x20are\x20<strong>histone\x20deacetylase\x20inhibitors</strong>.&nbsp;Vorinostat\x20is\x20approved\x20for\x20the\x20treatment\x20of\x20patients\x20with\x20cutaneous\x20T-cell\x20lymphoma\x20with\x20persistent\x20or\x20recurrent\x20disease\x20after\x20two\x20systemic\x20therapies.</p>','totalQuestions','SyTQp','warn','rzswe','A\x20patient\x20undergoing\x20treatment\x20for\x20HIV\x20complains\x20of\x20dizziness.\x20On\x20examination,\x20you\x20note\x20his\x20supine\x20BP\x20to\x20be\x20140/80\x20mmHg\x20and\x20standing\x20BP\x20to\x20be\x20110/70\x20mmHg.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20have\x20caused\x20this\x20condition?','\x22\x20data-option-index=\x22','xRXfP','src','Maraviroc','yDJbX','fzSAy','qFSgs','mJrjK','rMmEu','duFAC','solutionContainer','JQfTV','LSoHO','questionStates','mXDyE','startAt','VHnmy','UxIaJ','hsImL','CBWmE','cpIvA','AZkVb','CRwJK','UfXzF','RiSLS','4857kGbtBa','tMmAA','rJKjU','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','exception','Tipranavir','key','fill','CzHSC','A\x20patient\x20on\x20antiretroviral\x20therapy\x20comes\x20to\x20you\x20for\x20follow-up.\x20His\x20lipid\x20profile\x20reveals\x20high\x20cholesterol\x20levels.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20not\x20associated\x20with\x20this\x20condition?','pzCnj','VLQVd','attachMedia','<p\x20class=\x22p1\x22>The\x20given\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20<strong>adverse\x20effects</strong>\x20of&nbsp;gastrointestinal\x20tolerance\x20and\x20fat\x20redistribution\x20due\x20to&nbsp;<strong>protease\x20inhibitors</strong>.\x20HAART\x20therapy\x20includes\x20this\x20class\x20of\x20drugs\x20along\x20with\x202\x20nucleoside\x20reverse\x20transcriptase\x20inhibitors\x20+/-\x20NNRTIs.&nbsp;<strong>Ritonavir,&nbsp;</strong>not\x20tipranavir,\x20is\x20used\x20in\x20<strong>sub-therapeutic</strong>\x20<strong>doses</strong>\x20as\x20a\x20pharmacodynamic\x20booster\x20of\x20other\x20protease\x20inhibitors\x20in\x20cART.</p>\x0a<p>This\x20is\x20because\x20ritonavir\x20is\x20a\x20<strong>potent\x20inhibitor\x20</strong>of\x20the<strong>\x20CYP3A4</strong>\x20isoform\x20of\x20P450.\x20It\x20inhibits\x20their\x20CYP3A-mediated\x20metabolism\x20and\x20permits\x20the\x20use\x20of\x20lower\x20doses\x20of\x20other\x20protease\x20inhibitors.\x20Nelfinavir&nbsp;is\x20the\x20only\x20protease\x20inhibitor&nbsp;not\x20boosted&nbsp;by\x20ritonavir.</p>\x0a<p><strong>Indinavir</strong>\x20is\x20notable\x20for\x20its\x20tendency\x20to\x20precipitate\x20in\x20the\x20urinary\x20tract,\x20causing\x20<strong>nephrolithiasis</strong>,\x20unless\x20the\x20patient\x20maintains\x20a\x20high\x20state\x20of\x20hydration.</p>','ArfVT','gzzKr','5|4|0|2|3|1','RmDua','Abacavir','iZjdP','iodNO','XZXYL','RHmHj','HDjEj','Enfuviritide','esjfD','solutionText','studyModeLegend','VhAqa','shSHW','iASOe','UWgQy','oKwuq','szspQ','customQuizData','oYXrQ','none','kTrYw','LyxUa','egGHW','fzIAa','cGIrh','bookmarked','join','Increased\x20efflux\x20of\x20the\x20drug\x20from\x20inside\x20the\x20cell','solutionVideo','table','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','explanation_video','uJMaS','innerHTML','Zalcitabine','OIEzo','vdoPV','XHKTw','currentQuestion','fiFSW','trace','Magqo','scIhE','markReviewBtn','EaCeD','vTBGX','hLJXR','scoreCircle','syIVM','jdAdt','MtRHU','application/vnd.apple.mpegurl','not_attempted','\x20>\x20','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','<p><strong>Abacavir\x20</strong>is\x20a\x20guanosine\x20analogue\x20and\x20is\x20a\x20<strong>nucleoside\x20reverse\x20transcriptase\x20inhibitor.</strong></p>\x0a<p><strong>Raltegravir\x20</strong>is\x20an<strong>\x20integrase\x20inhibitor.</strong></p>\x0a<p>Nelfinavir,\x20saquinavir\x20and\x20ritonavir\x20are\x20protease\x20inhibitors.</p>','timeDisplay','tckcX','muCqV','red','KsMRl','CKHaN','Zropr','LgFOd','jLSnP','Atazanavir','nybRO','-600\x20text-white\x22>','OQfZn','totalAttempted','Lamivudine','LnSEp','testModeLegend','wPvET','YiGQk','HjYjg','<p><strong>Atazanavir</strong>\x20is\x20not\x20associated\x20with\x20dyslipidemia,\x20fat\x20redistribution,\x20or\x20metabolic\x20syndrome.\x20This\x20is\x20in\x20contrast\x20to\x20all\x20the\x20other\x20protease\x20inhibitors,\x20which\x20causes\x20side\x20effects\x20like\u00a0<strong>hypertriglyceridemia</strong>,\u00a0<strong>hypercholesterolemia</strong>\x20and\x20other\x20signs\x20of\x20<strong>lipodystrophy</strong>.\u00a0</p>\x0a<p>\u00a0Patients\x20treated\x20with\x20<strong>atazanavir</strong>\x20have\x20significantly\x20<strong>lower\x20fasting\x20triglyceride</strong>\x20and\x20<strong>cholesterol</strong>\x20concentrations\x20than\x20patients\x20treated\x20with\x20nelfinavir\x20and\x20lopinavir.\u00a0Clinically,\x20when\x20<strong>abacavir</strong>\x20(Nucleoside\x20Reverse\x20Transcriptase\x20Inhibitors)\u00a0is\x20substituted\x20for\x20protease\x20inhibitors\x20in\x20patients\x20having\x20dyslipidemia,\x20it\x20leads\x20to\x20an\x20i<strong>mprovement\x20in\x20lipid\x20profile</strong>.</p>','createElement','CD4','statsBar','questions','QsViB','zGQFb','toString','resume','wHkRk','quizFile','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','<p><strong>Indinavir</strong>,\x20a\x20protease\x20inhibitor,\x20is\x20the\x20most\x20likely\x20cause\x20for\x20these\x20adverse\x20effects.</p>\x0a<p>Patients\x20being\x20treated\x20with\x20<strong>protease</strong>\x20inhibitors\x20(e.g.,\x20indinavir)\x20develop\x20a\x20syndrome\x20involving\x20the\x20<strong>derangement</strong>\x20of\x20<strong>lipid\x20metabolism.</strong>\x20This\x20causes\x20changes\x20in\x20body\x20fat\x20distribution.\x20Type\x202\x20diabetes\x20mellitus\x20has\x20also\x20been\x20reported.\x20This\x20is\x20called&nbsp;<strong>HIV/HAART-associated\x20lipodystrophy.</strong></p>\x0a<p>Indinavir\x20can\x20also\x20<strong>precipitate</strong>\x20in\x20the\x20urinary\x20tract,\x20causing\x20<strong>nephrolithiasis,</strong>\x20unless\x20the\x20patient\x20is\x20maintained\x20in\x20a\x20high\x20state\x20of\x20hydration.</p>\x0a<p>Indinavir\x20binds\x20to\x20the\x20site\x20of\x20HIV-1\x20protease\x20activity\x20and\x20inhibits\x20cleavage\x20of\x20viral\x20gag-pol\x20polyprotein\x20precursors\x20into\x20individual\x20functional\x20proteins\x20required\x20for\x20infectious\x20HIV.\x20This\x20results\x20in\x20the\x20formation\x20of\x20immature,\x20non-infectious\x20viral\x20particles.</p>\x0a<p><strong>Option\x20A:</strong>\x20Azidothymidine\x20or&nbsp;zidovudine,\x20is\x20a\x20nucleoside\x20reverse\x20transcriptase\x20inhibitor.&nbsp;Chronic\x20zidovudine\x20administration\x20has\x20been\x20associated\x20with\x20nail\x20hyperpigmentation.&nbsp;</p>\x0a<p><strong>Option\x20C</strong>:\x20Ketoconazole\x20is\x20an\x20antifungal\x20agent\x20that\x20inhibits\x20fungal\x20ergosterol\x20synthesis.\x20Its\x20adverse\x20effects\x20include\x20liver\x20dysfunction\x20and\x20testosterone\x20synthesis\x20inhibition\x20leading\x20to\x20gynecomastia.&nbsp;</p>\x0a<p><strong>Option\x20D</strong>:\x20Lamivudine\x20is\x20a\x20nucleoside\x20reverse\x20transcriptase\x20inhibitor.&nbsp;It\x20is\x20one\x20of\x20the\x20least\x20toxic\x20antiretroviral\x20drugs.\x20Neutropenia,\x20headache,\x20and\x20nausea\x20have\x20been\x20reported\x20at\x20higher-than-recommended\x20doses.</p>','submitSection','120FfOypM','IDHdE','Raltegravir','solutionImages','push','click','get','VpsXz','optionsContainer','FrJMo','zkbgr','incorrectCount','currentMode','DRlgy','HqSWj','Nelfinavir','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','addEventListener','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','bookmarkText','Which\x20of\x20the\x20following\x20is\x20a\x20pharmacological\x20booster\x20with\x20no\x20antiretroviral\x20activity?','Rilpivirine','lzhkK','yfSTX','wCnig','KKQJq','questionNav','wMjOx','qrFVx','PhuJC','WjKgE','CRloe','LkNBE','uWkRr','nav-btn-correct','Yefbf','border-red-500','uRliS','SAxYu','jmfuk','JUPDL','<p><strong>Nevirapine</strong>\x20is\x20a\x20<strong>non-nucleoside\x20reverse\x20transcriptase\x20inhibitor</strong>\x20(NNRTI)</p>\x0a<p>US\x20FDA\x20has\x20approved\x20doravirine,\x20a\x20new\x20non-nucleoside\x20reverse\x20transcriptase\x20inhibitor(NNRTI)\x20for\x20the\x20treatment\x20of\x20adults\x20with\x20HIV-1\x20infection\x20given\x20in\x20combination\x20with\x20other\x20ARTs.</p>','bgMvI','OJomC','GyJQG','fJXfG','VsaiD','TyuiQ','VVzfg','ArrowRight','35-antiretroviral-drugs-636ea069.html','rQzGI','yoFXX','lxfKu','FmPLe','correctAnswers','jjLrr','cwCRU','yrsdQ','DUTFp','quTVV','txenV','correctCount','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','yISJf','constructor','Pharmacology','questionReviewSection','<p><strong>Antiviral</strong>\x20drug\x20having\x20<strong>dual\x20antiviral\x20activity</strong>\x20against\x20<strong>HIV</strong>\x20and\x20<strong>HBV</strong>\x20is\x20<strong>emtricitabine</strong>.</p>\x0a<p>It\x20is\x20a\x20<strong>nucleoside\x20reverse\x20transcriptase\x20inhibitor</strong>\x20similar\x20to\x20lamivudine.\x20It\x20has\x20activity\x20against\x20HIV-1,\x20HIV-2,\x20and\x20HBV.</p>','Of\x20all\x20the\x20nucleoside\x20reverse\x20transcriptase\x20inhibitors,\x20the\x20use\x20of\x20which\x20of\x20the\x20following\x20is\x20most\u00a0strongly\u00a0associated\x20with\x20fat\x20wasting?','Anti-HBe\x20seroconversion\x20occurs\x20in\x20a\x20minority\x20of\x20the\x20patients','testModeReviewLegend','Indinavir','EbCcJ','nJxZe','YKtqU','QyuFk','WgWMo','wKwsA','eehIF','xasSN','IqOTM','Amprenavir','sjakm','parse','markReviewText','QmNOu','fromCharCode','OFDNE','xrYiF','Bevacizumab','getAttribute','KZZIE','Mark\x20for\x20Review','CCR5\x20and\x20CD4','totalQuestionsResult','accuracyScore','MLZnQ','explanation_images','https://cdn1.dailyrounds.org/uploads/76b1fcce32a14af98378f43320c5ca9e.PNG','stats','FrFxG','Incorrect','BbhKy','EHFHk','questionText','XfYVD','bSveb','5|3|0|4|1|2','qBank','vYMRh','OrLyO','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','Option\x20','FZFgp','Didanosine','Bookmarked','VLagN','JjQMh','video[data-src]','rQQoP','iMvvh','Dqnzp','question_audio','Resistance\x20to\x20zidovudine\x20develops\x20due\x20to:','vUVWV','CXCR4','zhirF','bpSgn','.option-button','zCUcI','location','green','incorrect','MnVTi','Vorinostat','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'];_0x582e=function(){return _0x3701f2;};return _0x582e();}function jumpToQuestion(_0x507306){const _0x11c352=_0x148940,_0x24c49b={'LnRnZ':'button','EFJoK':function(_0x5e0e39,_0x1bdc4f){return _0x5e0e39+_0x1bdc4f;},'upAWT':_0x11c352(0x38f),'kULVO':function(_0x390364,_0x54d364){return _0x390364>=_0x54d364;},'iFiRH':function(_0x3b13a9,_0x41ffbf){return _0x3b13a9===_0x41ffbf;},'tMmAA':'MfgdP','yEREZ':_0x11c352(0x30c),'LkNBE':function(_0x119e0c,_0x1e42f5){return _0x119e0c-_0x1e42f5;},'BpHjB':function(_0x369f87){return _0x369f87();}};if(_0x24c49b[_0x11c352(0x388)](_0x507306,0x0)&&_0x507306<questionsData['length']){if(_0x24c49b[_0x11c352(0xfa)](_0x24c49b[_0x11c352(0x229)],_0x24c49b[_0x11c352(0x348)])){const _0x21a511=_0x15a69f['createElement'](_0x24c49b['LnRnZ']);_0x21a511[_0x11c352(0x1a7)]=_0x24c49b[_0x11c352(0x1fc)](_0x4bd5d6,0x1),_0x21a511['className']=_0x24c49b['upAWT'],_0x21a511[_0x11c352(0x345)]=()=>_0xcf2634(_0x2dafde),_0x21a511['id']=_0x11c352(0x32b)+_0x267567,_0x3c23be['appendChild'](_0x21a511);}else questionStartTime&&(questionStates[currentQuestionIndex][_0x11c352(0x37f)]+=_0x24c49b[_0x11c352(0x2b3)](Date[_0x11c352(0x129)](),questionStartTime)),currentQuestionIndex=_0x507306,_0x24c49b[_0x11c352(0x17d)](displayQuestion),_0x24c49b[_0x11c352(0x17d)](saveProgress);}}function updateStats(){const _0x7c1ffe=_0x148940,_0x5e17b3={'afnPN':_0x7c1ffe(0x121),'vklfP':_0x7c1ffe(0x1d0),'HDjEj':function(_0x4c2dc0,_0x50ee5e){return _0x4c2dc0===_0x50ee5e;},'qOaah':_0x7c1ffe(0x218),'qFSgs':_0x7c1ffe(0x27e),'esjfD':function(_0x42f017,_0x261db6){return _0x42f017/_0x261db6;},'tirln':_0x7c1ffe(0x17f),'cpIvA':function(_0x46bfac,_0x3d8b94){return _0x46bfac+_0x3d8b94;},'ihZAe':function(_0x10ede4,_0x2d8d0d){return _0x10ede4%_0x2d8d0d;},'Yefbf':function(_0x96333b,_0x5d899f){return _0x96333b+_0x5d899f;}};if(_0x5e17b3[_0x7c1ffe(0x23f)](currentMode,_0x7c1ffe(0xe2))||currentMode==='timed_study'){if(_0x7c1ffe(0x1c3)===_0x5e17b3[_0x7c1ffe(0xe6)])_0x2c1eb7(),_0x4fafad[_0x7c1ffe(0x1d5)](_0x5e17b3[_0x7c1ffe(0x155)])['style'][_0x7c1ffe(0x12d)]=_0x5e17b3[_0x7c1ffe(0x1b8)];else{document[_0x7c1ffe(0x1d5)](_0x7c1ffe(0x2d1))[_0x7c1ffe(0x1a7)]=stats['correctAnswers'],document[_0x7c1ffe(0x1d5)](_0x7c1ffe(0x29e))[_0x7c1ffe(0x1a7)]=stats['incorrectAnswers'],document[_0x7c1ffe(0x1d5)](_0x5e17b3[_0x7c1ffe(0x215)])[_0x7c1ffe(0x1a7)]=stats[_0x7c1ffe(0x27e)];const _0x301e00=stats['totalAttempted']>0x0?Math['round'](_0x5e17b3[_0x7c1ffe(0x241)](stats[_0x7c1ffe(0x2ca)],stats['totalAttempted'])*0x64):0x0;document[_0x7c1ffe(0x1d5)](_0x5e17b3[_0x7c1ffe(0x38b)])[_0x7c1ffe(0x1a7)]=_0x5e17b3[_0x7c1ffe(0x223)](_0x301e00,'%'),stats[_0x7c1ffe(0x1cf)]=questionStates[_0x7c1ffe(0x1b7)]((_0x362bdc,_0x3f97ca)=>_0x362bdc+_0x3f97ca[_0x7c1ffe(0x37f)],0x0);const _0x12ad4b=Math[_0x7c1ffe(0x10f)](stats['totalTime']/0x3e8),_0x16fb14=Math[_0x7c1ffe(0x10f)](_0x12ad4b/0x3c),_0x5c7e2e=_0x5e17b3['ihZAe'](_0x12ad4b,0x3c);document['getElementById'](_0x7c1ffe(0x37f))[_0x7c1ffe(0x1a7)]=_0x5e17b3['Yefbf'](_0x5e17b3[_0x7c1ffe(0x2b6)](_0x16fb14,':'),_0x5c7e2e['toString']()[_0x7c1ffe(0x35c)](0x2,'0'));}}}function setupVideo(_0xec5dc4,_0x472d7e){const _0x535986=_0x148940,_0x491038={'NWrjg':'data-option-index','mYZSc':function(_0x3e1f76,_0x16edf9){return _0x3e1f76(_0x16edf9);},'IcFfI':function(_0x561c0d,_0x3b9018){return _0x561c0d===_0x3b9018;},'jjLCC':_0x535986(0x1c4),'BbhKy':_0x535986(0x26c)};if(Hls[_0x535986(0xdb)]()){if(_0x491038[_0x535986(0x197)](_0x491038['jjLCC'],_0x491038[_0x535986(0x1b9)])){const _0x4d5d2d=new Hls();_0x4d5d2d['loadSource'](_0x472d7e),_0x4d5d2d[_0x535986(0x234)](_0xec5dc4);}else{const _0x3ee091=_0xf3b4cd(_0x100815[_0x535986(0x2ee)](_0x491038[_0x535986(0x193)]));_0x491038[_0x535986(0x1f0)](_0x1788f3,_0x3ee091);}}else _0xec5dc4['canPlayType'](_0x491038[_0x535986(0x2fa)])&&(_0xec5dc4[_0x535986(0x211)]=_0x472d7e);}function displayQuestion(){const _0x5e0402=_0x148940,_0x2a672b={'fmXlE':function(_0x211e99,_0x1682fe){return _0x211e99>=_0x1682fe;},'DzlsV':function(_0x41b677,_0x289e6e){return _0x41b677<_0x289e6e;},'PjDlP':function(_0x4ba06a,_0x1c2e26){return _0x4ba06a-_0x1c2e26;},'kAfSa':function(_0x137ece){return _0x137ece();},'SGcFj':_0x5e0402(0x38a),'MVFzR':function(_0x349832,_0x396992){return _0x349832+_0x396992;},'HzNly':function(_0x2dd526,_0x21f92b){return _0x2dd526===_0x21f92b;},'tNltj':_0x5e0402(0x385),'rWRMG':_0x5e0402(0x1cb),'LPuKS':function(_0x2aa2da,_0x348769){return _0x2aa2da+_0x348769;},'qrFVx':_0x5e0402(0x314),'ARIEf':_0x5e0402(0x2e4),'gDmcZ':function(_0xb96f13,_0x2fff97){return _0xb96f13(_0x2fff97);},'eehIF':_0x5e0402(0x19f),'phZut':_0x5e0402(0x121),'dTAgJ':_0x5e0402(0x1d0),'bILxU':function(_0x1a949f,_0x4e741d){return _0x1a949f===_0x4e741d;},'FAKPw':_0x5e0402(0x2fc),'scIhE':'No\x20questions\x20available\x20for\x20this\x20quiz.','jepDp':function(_0x9b3b87,_0x5c8855){return _0x9b3b87*_0x5c8855;},'uZYru':function(_0x4b1e81,_0x1168e2){return _0x4b1e81/_0x1168e2;},'iodNO':function(_0x2357cb,_0x9b4ce){return _0x2357cb+_0x9b4ce;},'rLqsW':_0x5e0402(0x131),'iQgBa':_0x5e0402(0x25f),'KKQJq':function(_0x295fa2,_0x536ae5){return _0x295fa2===_0x536ae5;},'HEdQD':'solutionContainer','NmdRW':'hidden','UxOAO':_0x5e0402(0x33f),'JPQUv':_0x5e0402(0x29b),'cjqSX':_0x5e0402(0x1b5),'XfYVD':_0x5e0402(0x298),'TBYWP':function(_0x232a61){return _0x232a61();},'rbGJm':function(_0x4f0a51,_0x2ee6e1){return _0x4f0a51===_0x2ee6e1;},'kSHpr':'timed_exam'};if(!questionsData||_0x2a672b['bILxU'](questionsData[_0x5e0402(0x331)],0x0)){document['getElementById'](_0x2a672b['FAKPw'])[_0x5e0402(0x25a)]=_0x2a672b[_0x5e0402(0x263)];return;};const _0x576548=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x39fa37=_0x2a672b['jepDp'](_0x2a672b[_0x5e0402(0x157)](_0x2a672b[_0x5e0402(0x23c)](currentQuestionIndex,0x1),questionsData['length']),0x64);document[_0x5e0402(0x1d5)](_0x2a672b[_0x5e0402(0x172)])[_0x5e0402(0x373)]['width']=_0x39fa37+'%',document[_0x5e0402(0x1d5)](_0x2a672b['iQgBa'])[_0x5e0402(0x1a7)]=_0x2a672b[_0x5e0402(0x23c)](currentQuestionIndex,0x1),_0x2a672b['kAfSa'](updateQuestionNav),document[_0x5e0402(0x1d5)]('prevBtn')[_0x5e0402(0x1e2)]=_0x2a672b[_0x5e0402(0x2ac)](currentQuestionIndex,0x0),document['getElementById'](_0x2a672b['HEdQD'])['classList'][_0x5e0402(0x1f1)](_0x2a672b[_0x5e0402(0x1c5)]),document['getElementById'](_0x2a672b[_0x5e0402(0x17b)])[_0x5e0402(0x25a)]=_0x576548[_0x5e0402(0x320)]||_0x5e0402(0x13e);let _0x5f31df='';if(_0x576548[_0x5e0402(0x30e)])_0x5f31df+=_0x5e0402(0x1c0)+_0x576548['question_audio']+_0x5e0402(0x290);if(_0x576548[_0x5e0402(0x114)])_0x5f31df+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x576548[_0x5e0402(0x114)]+_0x5e0402(0x15e);_0x576548[_0x5e0402(0x100)]&&_0x576548[_0x5e0402(0x100)]['forEach'](_0x568e89=>{const _0x49e9a1=_0x5e0402;if(_0x568e89)_0x5f31df+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0x568e89+_0x49e9a1(0xcd);});document[_0x5e0402(0x1d5)](_0x2a672b['UxOAO'])[_0x5e0402(0x25a)]=_0x5f31df;const _0x1e2048=document[_0x5e0402(0x1d5)](_0x2a672b[_0x5e0402(0x140)]);_0x1e2048[_0x5e0402(0x25a)]='',_0x1e2048[_0x5e0402(0x146)][_0x5e0402(0x389)](_0x5e0402(0x368)),_0x576548[_0x5e0402(0x360)]&&Array['isArray'](_0x576548['choices'])&&(_0x2a672b[_0x5e0402(0x125)](_0x2a672b[_0x5e0402(0x195)],_0x2a672b[_0x5e0402(0x195)])?(_0x576548[_0x5e0402(0x360)][_0x5e0402(0x1bd)]((_0x29c6ee,_0x4b8c29)=>{const _0x4066a8=_0x5e0402;if(_0x4066a8(0x132)!==_0x2a672b['SGcFj']){const _0x590878=String[_0x4066a8(0x2ea)](_0x2a672b[_0x4066a8(0x141)](0x41,_0x4b8c29)),_0x404ecc=_0x2a672b['HzNly'](selectedOption,_0x4b8c29),_0x25f10b=document['createElement'](_0x2a672b['tNltj']);_0x25f10b['innerHTML']='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x404ecc?_0x2a672b[_0x4066a8(0x160)]:'')+_0x4066a8(0x20f)+_0x4b8c29+_0x4066a8(0x34a)+_0x590878+_0x4066a8(0x35e)+(_0x29c6ee[_0x4066a8(0x320)]||_0x2a672b['LPuKS'](_0x4066a8(0x304),_0x2a672b[_0x4066a8(0x141)](_0x4b8c29,0x1)))+_0x4066a8(0x22b),_0x1e2048[_0x4066a8(0x1f5)](_0x25f10b);}else _0x2a672b[_0x4066a8(0x158)](_0x38ff38,0x0)&&_0x2a672b[_0x4066a8(0x36d)](_0x4fa796,_0x5926e7[_0x4066a8(0x331)])&&(_0x3bcaa5&&(_0x5478c4[_0x1f69c3][_0x4066a8(0x37f)]+=_0x2a672b[_0x4066a8(0x335)](_0xd8f843[_0x4066a8(0x129)](),_0x16718a)),_0x15cd2d=_0x1bf97d,_0x2a672b[_0x4066a8(0x33e)](_0x5a4bb6),_0x2a672b[_0x4066a8(0x33e)](_0x98a82c));}),_0x1e2048[_0x5e0402(0x2a4)](_0x2a672b[_0x5e0402(0x2fd)],function(_0x537601){const _0x54f2f7=_0x5e0402,_0x31fc11=_0x537601[_0x54f2f7(0x104)][_0x54f2f7(0x1e8)](_0x2a672b[_0x54f2f7(0x2af)]);if(_0x31fc11){if(_0x2a672b['HzNly']('IqOTM',_0x2a672b[_0x54f2f7(0x18e)])){const _0x163488=_0x2a672b['gDmcZ'](parseInt,_0x31fc11[_0x54f2f7(0x2ee)](_0x2a672b[_0x54f2f7(0x2e2)]));selectOption(_0x163488);}else{_0x39f918[_0x54f2f7(0x27e)]++,_0x57a4c7[_0x54f2f7(0x327)]--;if(_0x9d5d84)_0x2ef072[_0x54f2f7(0x2ca)]++;else _0x398e0d[_0x54f2f7(0x184)]++;}}})):(_0x2a672b['kAfSa'](_0x147679),_0x2fcebb['getElementById'](_0x2a672b[_0x5e0402(0x1a5)])[_0x5e0402(0x373)][_0x5e0402(0x12d)]=_0x2a672b['dTAgJ'])),_0x2a672b['TBYWP'](updateBookmarkButton),updateMarkReviewButton(),(_0x2a672b[_0x5e0402(0x350)](currentMode,_0x5e0402(0x1e6))||currentMode===_0x2a672b['kSHpr'])&&!isQuizCompleted&&_0x2a672b['TBYWP'](startTimer);}function selectOption(_0x461e15){const _0x1e386f=_0x148940,_0x36fe7e={'NzcfG':function(_0x14ef47,_0x411b11){return _0x14ef47===_0x411b11;},'UgelD':_0x1e386f(0x1c1),'KFkxS':_0x1e386f(0x1f9),'rXviF':'incorrect','qdept':_0x1e386f(0x2f9),'lgMip':function(_0x1eafcf,_0x3b5bd3){return _0x1eafcf!==_0x3b5bd3;},'wZcOP':_0x1e386f(0x149),'DCzXH':function(_0x56ea02,_0x102eea){return _0x56ea02===_0x102eea;},'sSSmc':'answered','ShSzD':function(_0x433bbf,_0x5a5b0e){return _0x433bbf-_0x5a5b0e;},'IZuyW':_0x1e386f(0x314),'kYriM':_0x1e386f(0xe2),'sXZVD':function(_0x2d5b83,_0x3e9416){return _0x2d5b83===_0x3e9416;},'gzzKr':_0x1e386f(0x18a),'KZZIE':function(_0x4ad74a){return _0x4ad74a();},'ndEsi':_0x1e386f(0x313),'MtRHU':function(_0xeeb006){return _0xeeb006();}},_0x325b69=document[_0x1e386f(0x1d5)](_0x1e386f(0x29b));if(_0x325b69[_0x1e386f(0x146)][_0x1e386f(0x181)](_0x36fe7e['sSSmc']))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x1e386f(0x37f)]+=_0x36fe7e[_0x1e386f(0x205)](Date['now'](),questionStartTime),questionStartTime=Date['now']()),selectedOption=_0x461e15,questionStates[currentQuestionIndex]['selectedAnswer']=_0x461e15,document['querySelectorAll'](_0x36fe7e[_0x1e386f(0x13a)])[_0x1e386f(0x1bd)]((_0x5158fd,_0x2ed02a)=>{const _0x307c28=_0x1e386f,_0xdc6168={'zkbgr':function(_0x579cfa,_0x1dad03){return _0x36fe7e['NzcfG'](_0x579cfa,_0x1dad03);},'xQLGl':_0x36fe7e['UgelD'],'sjakm':_0x36fe7e['KFkxS'],'PhuJC':_0x36fe7e[_0x307c28(0x33a)],'CRloe':_0x36fe7e['qdept']};if(_0x36fe7e['lgMip'](_0x307c28(0x29c),_0x36fe7e['wZcOP']))_0x5158fd['classList']['toggle'](_0x307c28(0x1cb),_0x36fe7e['DCzXH'](_0x2ed02a,_0x461e15));else{const _0xba2073=_0x1ef32c[_0x307c28(0x360)][_0x393700[_0x307c28(0x179)]];_0xdc6168[_0x307c28(0x29d)](_0xba2073['id'],_0x158547)?(_0x32b0fc=_0xdc6168['xQLGl'],_0x439523=_0xdc6168[_0x307c28(0x2e6)]):(_0x489e2d=_0xdc6168[_0x307c28(0x2b0)],_0x586284=_0xdc6168[_0x307c28(0x2b2)]);}}),currentMode===_0x36fe7e[_0x1e386f(0x356)]||_0x36fe7e['sXZVD'](currentMode,_0x1e386f(0x1e6))?_0x36fe7e['lgMip'](_0x1e386f(0x18a),_0x36fe7e[_0x1e386f(0x237)])?(_0x580cab++,_0x45feea[_0x1e386f(0x1e9)]=_0x36fe7e[_0x1e386f(0x1c2)]):_0x36fe7e['KZZIE'](processAnswer):_0x36fe7e['DCzXH'](_0x36fe7e['ndEsi'],_0x1e386f(0x394))?(_0xa4b470[_0x18d708][_0x1e386f(0x1e9)]=_0x36fe7e[_0x1e386f(0x33b)],_0x14b22e[_0x1e386f(0x27e)]++,_0x25f53e[_0x1e386f(0x327)]--):(_0x36fe7e[_0x1e386f(0x15d)](questionStates[currentQuestionIndex][_0x1e386f(0x1e9)],'not_attempted')&&(questionStates[currentQuestionIndex][_0x1e386f(0x1e9)]=_0x1e386f(0x368),stats[_0x1e386f(0x27e)]++,stats[_0x1e386f(0x327)]--),_0x36fe7e[_0x1e386f(0x26b)](updateQuestionNav)),_0x36fe7e[_0x1e386f(0x2ef)](saveProgress);}function processAnswer(){const _0x3a276b=_0x148940,_0x324041={'cwCRU':_0x3a276b(0x1a2),'DPjPL':function(_0x316509,_0x1f1d79){return _0x316509===_0x1f1d79;},'pzCnj':'not_attempted','FrFxG':_0x3a276b(0x1d9),'VLCRq':_0x3a276b(0x318),'CBWmE':function(_0x45d93c,_0x4c932c){return _0x45d93c(_0x4c932c);},'gKDmS':function(_0x38da7f){return _0x38da7f();}},_0xde01c1=questionsData[currentQuestionIndex],_0x3815ea=_0xde01c1[_0x3a276b(0x34f)];if(selectedOption===null)return;const _0x587baf=_0xde01c1['choices'][selectedOption],_0x21aa54=_0x587baf['id']===_0x3815ea;if(_0x324041[_0x3a276b(0x398)](questionStates[currentQuestionIndex][_0x3a276b(0x1e9)],_0x324041[_0x3a276b(0x232)])){if('daFFq'===_0x324041[_0x3a276b(0x2f8)])_0x297ab4[_0x3a276b(0x1d5)]('timerContainer')[_0x3a276b(0x146)][_0x3a276b(0x389)](_0x324041[_0x3a276b(0x2cc)]);else{stats[_0x3a276b(0x27e)]++,stats['notAttempted']--;if(_0x21aa54)stats[_0x3a276b(0x2ca)]++;else stats[_0x3a276b(0x184)]++;}}questionStates[currentQuestionIndex][_0x3a276b(0x1e9)]=_0x21aa54?_0x3a276b(0x1c1):_0x324041['VLCRq'],updateStats(),_0x324041[_0x3a276b(0x222)](showInlineFeedback,_0x21aa54),_0x324041['gKDmS'](updateQuestionNav);}function showInlineFeedback(_0x4d9ac7){const _0x49e4c0=_0x148940,_0x29688d={'YPcmt':function(_0x5cd7a6,_0x1c0b2a){return _0x5cd7a6===_0x1c0b2a;},'FUzGg':_0x49e4c0(0xe2),'lzhkK':_0x49e4c0(0x1e6),'wLPwn':_0x49e4c0(0x27e),'kQRud':function(_0xf57647,_0xf009a8){return _0xf57647>_0xf009a8;},'nybRO':function(_0x41c7d8,_0x591a54){return _0x41c7d8/_0x591a54;},'wzFoE':_0x49e4c0(0x17f),'Jjszv':function(_0x2ac6da,_0x77c430){return _0x2ac6da/_0x77c430;},'nBWpR':function(_0x3a5823,_0x427cae){return _0x3a5823%_0x427cae;},'HUCuL':_0x49e4c0(0x37f),'LfnAg':function(_0x564086,_0x4c73e3){return _0x564086+_0x4c73e3;},'IbeFm':function(_0x509cfb,_0x1f6b7b){return _0x509cfb===_0x1f6b7b;},'Dqnzp':_0x49e4c0(0x38c),'LcVRY':_0x49e4c0(0x1cb),'fJXfG':function(_0x16cdc7,_0x2d490c){return _0x16cdc7===_0x2d490c;},'ERuDf':_0x49e4c0(0x1c1),'EaCeD':_0x49e4c0(0x318),'ArfVT':function(_0x3c12bb,_0x170ac6){return _0x3c12bb!==_0x170ac6;},'pwQkH':_0x49e4c0(0x29b),'cGIrh':function(_0xe0fdd4){return _0xe0fdd4();}};if(_0x29688d[_0x49e4c0(0x236)](currentMode,_0x49e4c0(0xe2))&&_0x29688d['ArfVT'](currentMode,_0x29688d['lzhkK']))return;const _0x54f084=document['getElementById'](_0x29688d['pwQkH']),_0x398f50=_0x54f084[_0x49e4c0(0x201)]('.option-button'),_0xbb993b=questionsData[currentQuestionIndex],_0x1ca3cc=_0xbb993b[_0x49e4c0(0x34f)];let _0x27da69=_0xbb993b[_0x49e4c0(0x360)]['findIndex'](_0x2f0624=>_0x2f0624['id']===_0x1ca3cc);_0x54f084['classList'][_0x49e4c0(0x1f1)](_0x49e4c0(0x368)),_0x398f50['forEach']((_0x44d5fa,_0x1147f4)=>{const _0x1a9701=_0x49e4c0;if(_0x29688d['IbeFm'](_0x29688d[_0x1a9701(0x30d)],_0x1a9701(0x38c))){_0x44d5fa[_0x1a9701(0x146)]['remove'](_0x29688d[_0x1a9701(0x119)]);if(_0x29688d[_0x1a9701(0x2c0)](_0x1147f4,_0x27da69))_0x44d5fa[_0x1a9701(0x146)][_0x1a9701(0x1f1)](_0x29688d['ERuDf']);else{if(_0x29688d['IbeFm'](_0x1147f4,selectedOption)&&!_0x4d9ac7)_0x44d5fa['classList'][_0x1a9701(0x1f1)](_0x29688d[_0x1a9701(0x265)]);}}else{if(_0x29688d[_0x1a9701(0x349)](_0x309d57,_0x29688d['FUzGg'])||_0x4c5305===_0x29688d[_0x1a9701(0x2a9)]){_0x1f0b0d[_0x1a9701(0x1d5)](_0x1a9701(0x2d1))[_0x1a9701(0x1a7)]=_0x5a6d44[_0x1a9701(0x2ca)],_0x302419['getElementById'](_0x1a9701(0x29e))[_0x1a9701(0x1a7)]=_0x5196e2[_0x1a9701(0x184)],_0x57c77a[_0x1a9701(0x1d5)](_0x29688d[_0x1a9701(0xe7)])['textContent']=_0x5567f1[_0x1a9701(0x27e)];const _0x45330e=_0x29688d[_0x1a9701(0x18c)](_0x576b85['totalAttempted'],0x0)?_0x143ea2[_0x1a9701(0x1fe)](_0x29688d[_0x1a9701(0x27b)](_0x19d71f['correctAnswers'],_0x4194f2[_0x1a9701(0x27e)])*0x64):0x0;_0x48bc4b['getElementById'](_0x29688d[_0x1a9701(0x150)])[_0x1a9701(0x1a7)]=_0x45330e+'%',_0x1d7261[_0x1a9701(0x1cf)]=_0x16e46d['reduce']((_0xdeacfb,_0x5a87db)=>_0xdeacfb+_0x5a87db[_0x1a9701(0x37f)],0x0);const _0x1b97ca=_0x45f543[_0x1a9701(0x10f)](_0x29688d[_0x1a9701(0x187)](_0x574f3a[_0x1a9701(0x1cf)],0x3e8)),_0x26fd61=_0x36c8da[_0x1a9701(0x10f)](_0x1b97ca/0x3c),_0x1eac43=_0x29688d[_0x1a9701(0x208)](_0x1b97ca,0x3c);_0x504868[_0x1a9701(0x1d5)](_0x29688d['HUCuL'])[_0x1a9701(0x1a7)]=_0x29688d[_0x1a9701(0x34b)](_0x29688d['LfnAg'](_0x26fd61,':'),_0x1eac43[_0x1a9701(0x28c)]()[_0x1a9701(0x35c)](0x2,'0'));}}}),_0x29688d[_0x49e4c0(0x251)](showSolution);}function showSolution(){const _0x5a1b01=_0x148940,_0x2153dc={'lxfKu':function(_0x49ac22,_0x481637){return _0x49ac22-_0x481637;},'xRkUw':function(_0x4e26c5){return _0x4e26c5();},'lVBov':function(_0x23ff07,_0x556b53){return _0x23ff07===_0x556b53;},'syIVM':_0x5a1b01(0x385),'VhAqa':function(_0xe3adc5,_0x371874){return _0xe3adc5+_0x371874;},'mAIWn':_0x5a1b01(0x304),'afCyL':function(_0x39bfc8,_0xf88aa8){return _0x39bfc8+_0xf88aa8;},'RKpYQ':function(_0x538a9b,_0x1d25cc){return _0x538a9b!==_0x1d25cc;},'tgqLx':_0x5a1b01(0xe2),'IDHdE':_0x5a1b01(0x1e6),'WgWMo':_0x5a1b01(0x242),'OEUtY':_0x5a1b01(0x255),'hXckD':_0x5a1b01(0x358),'INpoZ':_0x5a1b01(0x363),'tULUF':_0x5a1b01(0x1a2),'igPbB':'.m3u8','jjLrr':function(_0xff33af,_0x5eda27,_0x8efa12){return _0xff33af(_0x5eda27,_0x8efa12);},'HsYBY':'solutionAudio','obRid':_0x5a1b01(0x219)};if(_0x2153dc[_0x5a1b01(0x144)](currentMode,_0x2153dc['tgqLx'])&&currentMode!==_0x2153dc[_0x5a1b01(0x294)])return;const _0x205d0b=questionsData[currentQuestionIndex];document['getElementById'](_0x2153dc[_0x5a1b01(0x2e0)])[_0x5a1b01(0x25a)]=_0x205d0b['solution']||_0x5a1b01(0x35b);const _0x53a324=document['getElementById'](_0x2153dc[_0x5a1b01(0x1ca)]),_0x50fb4e=document['getElementById'](_0x2153dc[_0x5a1b01(0x200)]),_0x16eec8=_0x205d0b['explanation_video'];if(_0x16eec8){if(_0x2153dc[_0x5a1b01(0x144)](_0x2153dc[_0x5a1b01(0x13d)],_0x5a1b01(0x363)))_0x32ae9a&&(_0x3eec88[_0x1af65f][_0x5a1b01(0x37f)]+=_0x2153dc[_0x5a1b01(0x2c8)](_0x5f135d[_0x5a1b01(0x129)](),_0x41cc31)),_0x8d1d46=_0x2cd0b2,_0x55da35(),_0x2153dc[_0x5a1b01(0x189)](_0x385530);else{_0x53a324[_0x5a1b01(0x146)][_0x5a1b01(0x389)](_0x2153dc['tULUF']);if(_0x16eec8[_0x5a1b01(0x1a8)](_0x2153dc['igPbB']))_0x2153dc[_0x5a1b01(0x2cb)](setupVideo,_0x50fb4e,_0x16eec8);else _0x50fb4e[_0x5a1b01(0x211)]=_0x16eec8;}}else _0x53a324[_0x5a1b01(0x146)][_0x5a1b01(0x1f1)](_0x2153dc[_0x5a1b01(0x1b6)]);const _0x225312=document[_0x5a1b01(0x1d5)](_0x2153dc[_0x5a1b01(0xf9)]);_0x225312[_0x5a1b01(0x25a)]='';if(_0x205d0b[_0x5a1b01(0x34e)]){if(_0x2153dc[_0x5a1b01(0x1ac)](_0x5a1b01(0x23e),_0x5a1b01(0x23e)))_0x225312['innerHTML']+=_0x5a1b01(0x1eb)+_0x205d0b[_0x5a1b01(0x34e)]+_0x5a1b01(0x290);else{const _0x170a7d=_0x5294c9['fromCharCode'](0x41+_0x1ca9a6),_0x17311a=_0x2153dc['lVBov'](_0x3af203,_0x52f86f),_0x19f9df=_0x5cc5ad[_0x5a1b01(0x286)](_0x2153dc[_0x5a1b01(0x269)]);_0x19f9df[_0x5a1b01(0x25a)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x17311a?_0x5a1b01(0x1cb):'')+'\x22\x20data-option-index=\x22'+_0x4e5f8b+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x170a7d+_0x5a1b01(0x35e)+(_0x44fe7a[_0x5a1b01(0x320)]||_0x2153dc[_0x5a1b01(0x244)](_0x2153dc[_0x5a1b01(0x372)],_0x2153dc['afCyL'](_0x4ba419,0x1)))+_0x5a1b01(0x22b),_0x558853[_0x5a1b01(0x1f5)](_0x19f9df);}}_0x205d0b[_0x5a1b01(0x103)]&&(_0x225312[_0x5a1b01(0x25a)]+=_0x5a1b01(0x357)+_0x205d0b[_0x5a1b01(0x103)]+_0x5a1b01(0x290));const _0x2264e9=document[_0x5a1b01(0x1d5)](_0x5a1b01(0x296));_0x2264e9['innerHTML']='',_0x205d0b[_0x5a1b01(0x2f5)]&&_0x205d0b[_0x5a1b01(0x2f5)]['forEach'](_0x4acad3=>{const _0x17a310=_0x5a1b01;if(_0x4acad3)_0x2264e9[_0x17a310(0x25a)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x4acad3+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}),document['getElementById'](_0x2153dc[_0x5a1b01(0xed)])['classList'][_0x5a1b01(0x389)](_0x2153dc[_0x5a1b01(0x1b6)]);}function submitQuiz(){const _0x7761a9=_0x148940,_0x15957c={'ExIVU':function(_0x278be4,_0x377f81){return _0x278be4===_0x377f81;},'lFeQN':_0x7761a9(0x1c1),'YKtqU':function(_0x3135d2,_0x51abcf){return _0x3135d2===_0x51abcf;},'tqhEH':'MMoUx','fzIAa':_0x7761a9(0x226),'SsuhB':'Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','Zropr':_0x7761a9(0xe3),'RURGg':function(_0x4aacd0,_0x46c7f4){return _0x4aacd0-_0x46c7f4;},'Gmtce':function(_0x37c9d5,_0x4c394f){return _0x37c9d5+_0x4c394f;},'KWUXN':function(_0x3ac5de){return _0x3ac5de();},'SpyzC':function(_0x454892,_0x131e39,_0x5cba4c,_0x380436,_0x52216c){return _0x454892(_0x131e39,_0x5cba4c,_0x380436,_0x52216c);},'tAirU':function(_0x119427,_0x21f849){return _0x119427+_0x21f849;}};if(timer)clearInterval(timer);if(!confirm(_0x15957c['SsuhB']))return;isQuizCompleted=!![];let _0x3e2d86=0x0,_0xb179bd=0x0;const _0x1dc872=Date[_0x7761a9(0x129)]()-quizStartTime;questionsData[_0x7761a9(0x1bd)]((_0xaed761,_0x1f67b1)=>{const _0x455cc6=_0x7761a9,_0x4a05ba=questionStates[_0x1f67b1];_0x4a05ba['selectedAnswer']!==null&&(_0x15957c[_0x455cc6(0x13b)](_0xaed761['choices'][_0x4a05ba[_0x455cc6(0x179)]]['id'],_0xaed761[_0x455cc6(0x34f)])?(_0x3e2d86++,_0x4a05ba['status']=_0x15957c[_0x455cc6(0xdf)]):_0x15957c[_0x455cc6(0x2de)](_0x15957c[_0x455cc6(0x37d)],_0x15957c[_0x455cc6(0x250)])?_0x3b7282[_0x455cc6(0x28f)][_0x455cc6(0x1a8)](_0x42c97b['toLowerCase']()[_0x455cc6(0x11d)](/ /g,'-'))&&(_0x366181[_0x455cc6(0x1ff)]<_0x88ed3e[_0x455cc6(0x331)]&&(_0x476914[_0x36af67[_0x455cc6(0x1ff)]][_0x455cc6(0x252)]=!![])):(_0xb179bd++,_0x4a05ba[_0x455cc6(0x1e9)]=_0x455cc6(0x318)));});const _0x33f1d2=JSON[_0x7761a9(0x2e7)](localStorage[_0x7761a9(0xd7)](_0x15957c[_0x7761a9(0x277)]))||[];_0x33f1d2[_0x7761a9(0x297)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x7761a9(0x129)](),'totalTime':_0x1dc872,'stats':{'correct':_0x3e2d86,'incorrect':_0xb179bd,'notAttempted':_0x15957c[_0x7761a9(0x188)](questionsData[_0x7761a9(0x331)],_0x15957c[_0x7761a9(0x1a1)](_0x3e2d86,_0xb179bd))}}),localStorage['setItem'](_0x7761a9(0xe3),JSON['stringify'](_0x33f1d2)),stats[_0x7761a9(0x2ca)]=_0x3e2d86,stats['incorrectAnswers']=_0xb179bd,_0x15957c[_0x7761a9(0x31c)](markQuizAsCompleted),_0x15957c[_0x7761a9(0x19a)](showPerformanceAnalysis,_0x3e2d86,_0xb179bd,questionsData[_0x7761a9(0x331)]-_0x15957c['tAirU'](_0x3e2d86,_0xb179bd),_0x1dc872);}function showPerformanceAnalysis(_0x5067ec,_0x2f87c1,_0x25dec9,_0x9dd6b1){const _0xc23e94=_0x148940,_0x5ac034={'cgHxj':function(_0xc7c950,_0xbc51ba){return _0xc7c950>_0xbc51ba;},'gAUsW':function(_0x52d40b,_0x2065c5){return _0x52d40b+_0x2065c5;},'eVfye':function(_0xa4d765,_0x43e662){return _0xa4d765*_0x43e662;},'Jgcoy':function(_0x132910,_0x26edaa){return _0x132910*_0x26edaa;},'lwPIS':_0xc23e94(0x268),'rYlKl':function(_0x135b29,_0x2554dd){return _0x135b29*_0x2554dd;},'usswQ':function(_0x567d9e,_0x3c1c5a){return _0x567d9e/_0x3c1c5a;},'dmOeU':_0xc23e94(0x2f2),'txenV':_0xc23e94(0x1ed),'gNIXh':'incorrectResult','JjQMh':function(_0x4e1f7a,_0x2a168d){return _0x4e1f7a/_0x2a168d;},'muCqV':function(_0x3592ef,_0x585d16){return _0x3592ef/_0x585d16;},'rkSht':function(_0x56af70,_0x5d39e3){return _0x56af70%_0x5d39e3;},'nJxZe':'totalTimeResult','EOZOi':function(_0x16d713,_0x5ce0e7){return _0x16d713/_0x5ce0e7;},'YZIOO':'hidden'},_0x516c44=document[_0xc23e94(0x1d5)]('performanceModal'),_0x25a8a1=_0x5ac034['cgHxj'](_0x5ac034[_0xc23e94(0x173)](_0x5067ec,_0x2f87c1),0x0)?Math[_0xc23e94(0x1fe)](_0x5ac034['eVfye'](_0x5067ec/_0x5ac034[_0xc23e94(0x173)](_0x5067ec,_0x2f87c1),0x64)):0x0,_0x5cf232=_0x5ac034[_0xc23e94(0x15b)](_0x5ac034[_0xc23e94(0x340)](0x2,Math['PI']),0x41),_0x4651f9=document[_0xc23e94(0x1d5)](_0x5ac034[_0xc23e94(0xee)]);_0x4651f9[_0xc23e94(0x373)][_0xc23e94(0x321)]=_0x5cf232+'\x20'+_0x5cf232,_0x4651f9[_0xc23e94(0x373)][_0xc23e94(0xf1)]=_0x5cf232-_0x5ac034['rYlKl'](_0x5ac034[_0xc23e94(0x1e7)](_0x25a8a1,0x64),_0x5cf232),document[_0xc23e94(0x1d5)](_0xc23e94(0x2f3))[_0xc23e94(0x1a7)]=_0x25a8a1+'%',document['getElementById'](_0x5ac034[_0xc23e94(0x1e4)])[_0xc23e94(0x1a7)]=questionsData[_0xc23e94(0x331)],document[_0xc23e94(0x1d5)](_0x5ac034[_0xc23e94(0x2d0)])[_0xc23e94(0x1a7)]=_0x5067ec,document[_0xc23e94(0x1d5)](_0x5ac034[_0xc23e94(0x112)])[_0xc23e94(0x1a7)]=_0x2f87c1,document['getElementById'](_0xc23e94(0x15c))[_0xc23e94(0x1a7)]=_0x25dec9;const _0x206b61=Math[_0xc23e94(0x10f)](_0x5ac034[_0xc23e94(0x309)](_0x9dd6b1,0xea60)),_0x3df4f4=Math[_0xc23e94(0x10f)](_0x5ac034[_0xc23e94(0x273)](_0x5ac034[_0xc23e94(0x14b)](_0x9dd6b1,0xea60),0x3e8));document[_0xc23e94(0x1d5)](_0x5ac034[_0xc23e94(0x2dd)])[_0xc23e94(0x1a7)]=_0x206b61+':'+_0x3df4f4[_0xc23e94(0x28c)]()[_0xc23e94(0x35c)](0x2,'0');const _0x19ed08=_0x5ac034[_0xc23e94(0x127)](_0x9dd6b1,questionsData[_0xc23e94(0x331)]),_0x49011d=Math[_0xc23e94(0x10f)](_0x19ed08/0xea60),_0x358d98=Math[_0xc23e94(0x10f)](_0x5ac034[_0xc23e94(0x309)](_0x5ac034[_0xc23e94(0x14b)](_0x19ed08,0xea60),0x3e8));document[_0xc23e94(0x1d5)](_0xc23e94(0x1d7))[_0xc23e94(0x1a7)]=_0x49011d+':'+_0x358d98[_0xc23e94(0x28c)]()[_0xc23e94(0x35c)](0x2,'0'),_0x516c44[_0xc23e94(0x146)][_0xc23e94(0x389)](_0x5ac034[_0xc23e94(0xea)]);}function closePerformanceModal(){const _0x3e54ba=_0x148940,_0x5e15d9={'yPkiL':_0x3e54ba(0x1a2)};document[_0x3e54ba(0x1d5)](_0x3e54ba(0xe0))[_0x3e54ba(0x146)]['add'](_0x5e15d9['yPkiL']);}function reviewQuestions(){const _0x4fac8f=_0x148940,_0x159085={'QsViB':function(_0x261767,_0x54b3b0){return _0x261767(_0x54b3b0);},'yfSTX':function(_0x5bd502,_0x1678dd){return _0x5bd502+_0x1678dd;},'OegSO':'return\x20(function()\x20','hhdNO':_0x4fac8f(0x10b),'KNHee':function(_0x2be39d){return _0x2be39d();},'cjQla':function(_0xf09bc2,_0x203ef7){return _0xf09bc2===_0x203ef7;},'wKwsA':_0x4fac8f(0x2b7),'hVEuw':'not-attempted','OFDNE':_0x4fac8f(0xf8),'RmDua':function(_0x51a7ac,_0x2f1256){return _0x51a7ac!==_0x2f1256;},'NRaKS':_0x4fac8f(0x1c1),'RyPee':_0x4fac8f(0x1f9),'EHFHk':_0x4fac8f(0x366),'WelPk':_0x4fac8f(0x32c),'RiSLS':_0x4fac8f(0x318),'qqHaf':_0x4fac8f(0x2f9),'TyuiQ':_0x4fac8f(0x385),'XZXYL':_0x4fac8f(0x317),'TIMFf':function(_0x494273,_0x421101){return _0x494273===_0x421101;},'bSveb':_0x4fac8f(0x274),'HGoob':_0x4fac8f(0x392),'jmfuk':'No\x20solution\x20available.','YVzQc':_0x4fac8f(0x2d6),'BnzTs':_0x4fac8f(0x1a2),'lBmQK':_0x4fac8f(0x1a9),'KmFQo':function(_0x5cc217){return _0x5cc217();}};document['getElementById'](_0x159085['YVzQc'])[_0x4fac8f(0x146)][_0x4fac8f(0x389)](_0x159085[_0x4fac8f(0xd9)]);const _0x1cf95b=document[_0x4fac8f(0x1d5)](_0x159085[_0x4fac8f(0x183)]);_0x1cf95b[_0x4fac8f(0x25a)]='',questionsData[_0x4fac8f(0x1bd)]((_0x4ebc85,_0x1e0509)=>{const _0x4ec379=_0x4fac8f,_0x369488=questionStates[_0x1e0509],_0x1fbfe9=_0x4ebc85[_0x4ec379(0x34f)];let _0x349252=_0x159085[_0x4ec379(0x133)],_0x6d4df8=_0x159085[_0x4ec379(0x2eb)];if(_0x159085[_0x4ec379(0x239)](_0x369488[_0x4ec379(0x179)],null)){const _0x5d0241=_0x4ebc85[_0x4ec379(0x360)][_0x369488[_0x4ec379(0x179)]];if(_0x5d0241['id']===_0x1fbfe9)_0x349252=_0x159085['NRaKS'],_0x6d4df8=_0x159085[_0x4ec379(0xf4)];else{if(_0x159085[_0x4ec379(0x2fb)]!==_0x159085[_0x4ec379(0x167)])_0x349252=_0x159085[_0x4ec379(0x227)],_0x6d4df8=_0x159085[_0x4ec379(0x1e0)];else{const _0xf58160=SDhyTZ[_0x4ec379(0x28a)](_0x595366,SDhyTZ[_0x4ec379(0x2aa)](SDhyTZ[_0x4ec379(0xcc)]+SDhyTZ[_0x4ec379(0x145)],');'));_0xcdc293=SDhyTZ[_0x4ec379(0x12c)](_0xf58160);}}}const _0x3d7b7c=document['createElement'](_0x159085[_0x4ec379(0x2c2)]);_0x3d7b7c[_0x4ec379(0x36c)]=_0x4ec379(0x177)+_0x349252;let _0x14533b=(_0x4ebc85[_0x4ec379(0x360)]||[])[_0x4ec379(0x362)]((_0x3d3b92,_0xc1fb11)=>{const _0x48bc72=_0x4ec379,_0x4153c3=_0x369488['selectedAnswer']===_0xc1fb11,_0x2c3ebb=_0x159085[_0x48bc72(0x175)](_0x3d3b92['id'],_0x1fbfe9);let _0x595311=_0x48bc72(0x1bf);if(_0x2c3ebb)_0x595311=_0x48bc72(0xff);else{if(_0x4153c3)_0x595311=_0x159085[_0x48bc72(0x2e1)];}return _0x48bc72(0x120)+_0x595311+_0x48bc72(0x2d2)+String[_0x48bc72(0x2ea)](0x41+_0xc1fb11)+'</span><span>'+_0x3d3b92[_0x48bc72(0x320)]+'</span></div>';})[_0x4ec379(0x253)]('');const _0x415ca7=_0x4ebc85[_0x4ec379(0x258)]?_0x4ec379(0x152)+_0x1e0509+_0x4ec379(0x134)+_0x4ebc85[_0x4ec379(0x258)]+_0x4ec379(0x2a3):'';let _0x181b66='';if(_0x4ebc85[_0x4ec379(0x34e)])_0x181b66+=_0x4ec379(0x1f3)+_0x4ebc85[_0x4ec379(0x34e)]+_0x4ec379(0x290);if(_0x4ebc85[_0x4ec379(0x103)])_0x181b66+=_0x4ec379(0x257)+_0x4ebc85[_0x4ec379(0x103)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x4d3217=(_0x4ebc85[_0x4ec379(0x2f5)]||[])[_0x4ec379(0x362)](_0x9cb702=>_0x9cb702?_0x4ec379(0xce)+_0x9cb702+_0x4ec379(0x386):'')[_0x4ec379(0x253)]('');_0x3d7b7c[_0x4ec379(0x25a)]=_0x4ec379(0x31b)+(_0x1e0509+0x1)+_0x4ec379(0x303)+(_0x159085[_0x4ec379(0x175)](_0x349252,_0x159085[_0x4ec379(0x10a)])?_0x159085[_0x4ec379(0x23d)]:_0x159085[_0x4ec379(0x35a)](_0x349252,_0x159085['RiSLS'])?_0x159085[_0x4ec379(0x2fe)]:_0x159085[_0x4ec379(0x1cc)])+_0x4ec379(0x27c)+_0x6d4df8+'</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>'+_0x4ebc85[_0x4ec379(0x320)]+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>'+_0x14533b+_0x4ec379(0xe5)+(_0x4ebc85[_0x4ec379(0x347)]||_0x159085[_0x4ec379(0x2ba)])+_0x4ec379(0x186)+_0x415ca7+_0x4ec379(0x1f4)+_0x181b66+_0x4ec379(0x1f4)+_0x4d3217+_0x4ec379(0x351),_0x1cf95b['appendChild'](_0x3d7b7c);}),_0x159085[_0x4fac8f(0xeb)](initializeReviewVideos);}function initializeReviewVideos(){const _0x3beff4=_0x148940,_0x3364e4={'yoEuM':_0x3beff4(0x387),'HEitr':function(_0x3a96d1,_0x261980,_0x3af6e0){return _0x3a96d1(_0x261980,_0x3af6e0);},'WjKgE':_0x3beff4(0x30a),'wCnig':_0x3beff4(0x1d6),'ApEUY':function(_0x2059fc,_0x9c5253){return _0x2059fc===_0x9c5253;},'AZTvI':_0x3beff4(0x28b)};document[_0x3beff4(0x201)](_0x3364e4[_0x3beff4(0x2b1)])[_0x3beff4(0x1bd)](_0x4ff274=>{const _0x1b2b26=_0x3beff4;if(_0x3364e4[_0x1b2b26(0x2ab)]===_0x3364e4['wCnig']){const _0x595cfb=_0x4ff274[_0x1b2b26(0x39a)]['src'];if(_0x595cfb&&_0x595cfb[_0x1b2b26(0x1a8)](_0x3364e4[_0x1b2b26(0x354)]))setupVideo(_0x4ff274,_0x595cfb);else{if(_0x595cfb){if(_0x3364e4['ApEUY'](_0x3364e4[_0x1b2b26(0x154)],_0x1b2b26(0x28b)))_0x4ff274[_0x1b2b26(0x211)]=_0x595cfb;else{const _0x439861={'gYXBU':_0x3364e4[_0x1b2b26(0x354)],'DYhfl':function(_0x17074c,_0x2659ba,_0x48e8ad){const _0xf7bfab=_0x1b2b26;return _0x3364e4[_0xf7bfab(0x336)](_0x17074c,_0x2659ba,_0x48e8ad);}};_0x48c517[_0x1b2b26(0x201)](_0x3364e4[_0x1b2b26(0x2b1)])['forEach'](_0x53b823=>{const _0x5e1b10=_0x1b2b26,_0xeb1f4=_0x53b823[_0x5e1b10(0x39a)][_0x5e1b10(0x211)];if(_0xeb1f4&&_0xeb1f4[_0x5e1b10(0x1a8)](_0x439861[_0x5e1b10(0x1df)]))_0x439861['DYhfl'](_0x426cd7,_0x53b823,_0xeb1f4);else _0xeb1f4&&(_0x53b823[_0x5e1b10(0x211)]=_0xeb1f4);});}}}}else _0x5b7a5e=_0x48a5f1;});}function retakeQuiz(){const _0x11964a=_0x148940,_0x286ab5={'XImHi':function(_0xa9cfb3,_0x2b5685){return _0xa9cfb3(_0x2b5685);},'jLSnP':_0x11964a(0x16d),'stlYg':_0x11964a(0x343),'PqFPf':_0x11964a(0x24a)};_0x286ab5[_0x11964a(0x1c8)](confirm,_0x286ab5[_0x11964a(0x279)])&&(window['location'][_0x11964a(0x16c)]['endsWith'](_0x286ab5[_0x11964a(0x130)])&&localStorage[_0x11964a(0x38e)](_0x286ab5[_0x11964a(0x207)]),clearProgress(),location['reload']());}function _0x5ab2(_0x1a61d1,_0x5d0619){const _0x514cc3=_0x582e();return _0x5ab2=function(_0x4bbdc6,_0x2512c0){_0x4bbdc6=_0x4bbdc6-0xcb;let _0x67bb4e=_0x514cc3[_0x4bbdc6];return _0x67bb4e;},_0x5ab2(_0x1a61d1,_0x5d0619);}function loadBookmarkedQuestions(){const _0x3a7822=_0x148940,_0xa7f980={'wHkRk':function(_0x265789,_0x2a56d3){return _0x265789<_0x2a56d3;},'YPSQE':_0x3a7822(0x324)},_0x5c4c1a=JSON['parse'](localStorage['getItem'](_0xa7f980[_0x3a7822(0x11b)]))||[];_0x5c4c1a[_0x3a7822(0x1bd)](_0x377a43=>{const _0x365cfb=_0x3a7822;_0x377a43[_0x365cfb(0x28f)]['includes'](quizName[_0x365cfb(0x101)]()['replace'](/ /g,'-'))&&(_0xa7f980[_0x365cfb(0x28e)](_0x377a43['questionIndex'],questionsData[_0x365cfb(0x331)])&&(questionStates[_0x377a43[_0x365cfb(0x1ff)]][_0x365cfb(0x252)]=!![]));});}function toggleBookmark(){const _0x3086c7=_0x148940,_0x3cfc59={'fzrei':function(_0xcdd998,_0x4e65ee){return _0xcdd998===_0x4e65ee;},'QyuFk':_0x3086c7(0x381),'HqSWj':'bookmarkedQuestions','YXqfK':function(_0x16add4){return _0x16add4();}},_0x189e52=!questionStates[currentQuestionIndex][_0x3086c7(0x252)];questionStates[currentQuestionIndex]['bookmarked']=_0x189e52;let _0x1d528b=JSON[_0x3086c7(0x2e7)](localStorage[_0x3086c7(0xd7)](_0x3086c7(0x324)))||[];if(_0x189e52){if(_0x3cfc59[_0x3086c7(0xf3)](_0x3cfc59[_0x3086c7(0x2df)],_0x3cfc59['QyuFk'])){const _0x1068a6={'quizName':quizName,'quizFile':window['location'][_0x3086c7(0x16c)]['split']('/')[_0x3086c7(0x11c)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x3086c7(0x129)]()};_0x1d528b[_0x3086c7(0x297)](_0x1068a6);}else{const _0x4714c6=_0x52c8e5[_0x3086c7(0xfc)](_0x18dd3f,arguments);return _0x1758a7=null,_0x4714c6;}}else _0x1d528b=_0x1d528b[_0x3086c7(0xda)](_0x108b36=>!(_0x108b36[_0x3086c7(0x28f)][_0x3086c7(0x1a8)](quizName[_0x3086c7(0x101)]()[_0x3086c7(0x11d)](/ /g,'-'))&&_0x108b36[_0x3086c7(0x1ff)]===currentQuestionIndex));localStorage[_0x3086c7(0x1dd)](_0x3cfc59[_0x3086c7(0x2a1)],JSON[_0x3086c7(0x1a3)](_0x1d528b)),_0x3cfc59['YXqfK'](updateBookmarkButton),updateQuestionNav();}function updateBookmarkButton(){const _0x56d271=_0x148940,_0x37e5a5={'rMmEu':'bookmarkBtn','kKzLU':_0x56d271(0x111),'egGHW':_0x56d271(0x37c),'CBTHs':_0x56d271(0x307),'gJnNQ':_0x56d271(0x139)},_0xd7e856=document[_0x56d271(0x1d5)](_0x37e5a5[_0x56d271(0x217)]),_0x5a1fcf=document[_0x56d271(0x1d5)](_0x56d271(0x2a6)),_0xa8d3fc=questionStates[currentQuestionIndex]['bookmarked'];_0xd7e856['className']=_0xa8d3fc?_0x37e5a5[_0x56d271(0x169)]:_0x37e5a5[_0x56d271(0x24f)],_0x5a1fcf[_0x56d271(0x1a7)]=_0xa8d3fc?_0x37e5a5['CBTHs']:_0x37e5a5[_0x56d271(0x35d)];}function toggleMarkForReview(){const _0x3fc099=_0x148940,_0x357880={'XxZXp':function(_0x3640f4){return _0x3640f4();}};questionStates[currentQuestionIndex][_0x3fc099(0x1ab)]=!questionStates[currentQuestionIndex]['markedForReview'],updateMarkReviewButton(),_0x357880['XxZXp'](updateQuestionNav);}function updateMarkReviewButton(){const _0xf7adc0=_0x148940,_0xaa0fc7={'uJMaS':_0xf7adc0(0x264),'oBXdN':'gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','lVXhc':_0xf7adc0(0x26f),'dnCGu':_0xf7adc0(0x1b1)},_0xea24ca=document[_0xf7adc0(0x1d5)](_0xaa0fc7[_0xf7adc0(0x259)]),_0xb34288=document['getElementById'](_0xf7adc0(0x2e8)),_0x1c5335=questionStates[currentQuestionIndex][_0xf7adc0(0x1ab)];_0xea24ca['className']=_0x1c5335?_0xaa0fc7[_0xf7adc0(0x1f6)]:_0xaa0fc7['lVXhc'],_0xb34288['textContent']=_0x1c5335?_0xaa0fc7[_0xf7adc0(0x206)]:_0xf7adc0(0x2f0);}function previousQuestion(){const _0x2cb145=_0x148940,_0x15a180={'iCVZZ':function(_0x30a249){return _0x30a249();},'hLJXR':_0x2cb145(0x121),'quTVV':_0x2cb145(0x24c),'dqTiC':function(_0x76d2e7){return _0x76d2e7();},'CHjSW':'flex','JUPDL':function(_0x1a7341,_0x263212){return _0x1a7341>_0x263212;},'TIfah':_0x2cb145(0x170),'HjYjg':function(_0x46a1f1,_0x533c9f){return _0x46a1f1===_0x533c9f;},'YiGQk':_0x2cb145(0x21b),'vKSOw':function(_0x44ab9b,_0x1dcd73){return _0x44ab9b-_0x1dcd73;},'wMjOx':function(_0x35bbd2){return _0x35bbd2();}};_0x15a180[_0x2cb145(0x2bb)](currentQuestionIndex,0x0)&&(_0x15a180[_0x2cb145(0x126)]!==_0x15a180[_0x2cb145(0x126)]?_0x15a180[_0x2cb145(0x174)](_0x247958):(questionStartTime&&(_0x15a180[_0x2cb145(0x284)](_0x2cb145(0x21b),_0x15a180[_0x2cb145(0x283)])?questionStates[currentQuestionIndex][_0x2cb145(0x37f)]+=_0x15a180[_0x2cb145(0x18f)](Date[_0x2cb145(0x129)](),questionStartTime):_0x15a180[_0x2cb145(0x174)](_0x1be8d2)?(_0x3e4b48[_0x2cb145(0x1d5)](_0x15a180[_0x2cb145(0x267)])[_0x2cb145(0x373)][_0x2cb145(0x12d)]=_0x15a180[_0x2cb145(0x2cf)],_0x15a180[_0x2cb145(0x396)](_0x11fd48)):(_0x15a180[_0x2cb145(0x174)](_0x17c005),_0x3208ec['getElementById'](_0x15a180['hLJXR'])[_0x2cb145(0x373)][_0x2cb145(0x12d)]=_0x15a180[_0x2cb145(0x384)])),currentQuestionIndex--,_0x15a180[_0x2cb145(0x174)](displayQuestion),_0x15a180[_0x2cb145(0x2ae)](saveProgress)));}function nextQuestion(){const _0x17d5cd=_0x148940,_0x417f40={'urtwU':_0x17d5cd(0x24a),'oKwuq':function(_0x390f0c){return _0x390f0c();},'BJipE':function(_0x20e3e1,_0x3a6fae){return _0x20e3e1-_0x3a6fae;},'IDZJc':function(_0x23d20c,_0x5c9dba){return _0x23d20c<_0x5c9dba;},'lbmAx':function(_0x402189,_0x18e3d5){return _0x402189!==_0x18e3d5;},'MLZnQ':_0x17d5cd(0x225),'gpBVF':function(_0x5f2900,_0x1affa5){return _0x5f2900===_0x1affa5;},'rowpQ':function(_0x44a999,_0x5537b7){return _0x44a999===_0x5537b7;},'VJkNk':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','unitX':function(_0xd25b0a,_0x3781b9){return _0xd25b0a(_0x3781b9);},'DRlgy':function(_0x251f85){return _0x251f85();},'BVgZd':function(_0x2bf531){return _0x2bf531();}};questionStartTime&&(questionStates[currentQuestionIndex][_0x17d5cd(0x37f)]+=_0x417f40[_0x17d5cd(0x377)](Date[_0x17d5cd(0x129)](),questionStartTime)),_0x417f40['IDZJc'](currentQuestionIndex,_0x417f40['BJipE'](questionsData[_0x17d5cd(0x331)],0x1))?_0x417f40[_0x17d5cd(0x1a0)](_0x417f40[_0x17d5cd(0x2f4)],_0x417f40[_0x17d5cd(0x2f4)])?(_0x4e7482[_0x17d5cd(0x316)][_0x17d5cd(0x16c)][_0x17d5cd(0xec)](_0x17d5cd(0x343))&&_0x1774ce['removeItem'](_0x417f40[_0x17d5cd(0x1da)]),_0x417f40['oKwuq'](_0xf3e190),_0x1097b0[_0x17d5cd(0x397)]()):(currentQuestionIndex++,_0x417f40[_0x17d5cd(0x248)](displayQuestion),saveProgress()):_0x417f40[_0x17d5cd(0x1d2)](currentMode,_0x17d5cd(0x37b))||_0x417f40['rowpQ'](currentMode,_0x17d5cd(0x107))?confirm(_0x417f40[_0x17d5cd(0x147)])&&submitQuiz():_0x417f40['unitX'](confirm,_0x17d5cd(0x192))&&(currentQuestionIndex=0x0,_0x417f40[_0x17d5cd(0x2a0)](displayQuestion),_0x417f40[_0x17d5cd(0x17a)](saveProgress));}function startTimer(){const _0x124c89=_0x148940,_0x424578={'MNRgC':function(_0x50ed60){return _0x50ed60();},'UWgQy':function(_0x4945ff,_0xbed86){return _0x4945ff!==_0xbed86;},'XZSqz':'timed_study','SyTQp':_0x124c89(0x29b),'WeHJs':_0x124c89(0x314),'FYRhF':'answered','JJmji':_0x124c89(0x1cb),'DUTFp':_0x124c89(0xd1),'XENwD':function(_0x3275dd,_0x28ab7d){return _0x3275dd<=_0x28ab7d;},'caIlE':function(_0x3caf8d,_0x2ee49c){return _0x3caf8d===_0x2ee49c;},'iDtRa':_0x124c89(0xfb),'VLQVd':function(_0x2ab151,_0x459876){return _0x2ab151(_0x459876);},'VcMhl':function(_0x5be6e9,_0x43fa7b){return _0x5be6e9===_0x43fa7b;},'dEbwJ':_0x124c89(0x107),'MkxqT':function(_0x52d8c3,_0x49d7f0){return _0x52d8c3!==_0x49d7f0;},'FaEgr':'fiFSW','fpLZo':function(_0x3d23e5,_0x54c7cc){return _0x3d23e5===_0x54c7cc;},'jHNQh':'nwsbP','IOFwG':function(_0x50d738){return _0x50d738();}};if(timer)_0x424578[_0x124c89(0x233)](clearInterval,timer);timeRemaining=0x78,_0x424578[_0x124c89(0x390)](updateTimerDisplay),timer=setInterval(()=>{const _0x2ddd74=_0x124c89,_0x520263={'kTrYw':_0x2ddd74(0x2ff),'Hfsjk':_0x424578['JJmji'],'ERJFx':function(_0xb4a539,_0x2334d3){return _0xb4a539===_0x2334d3;}};if(_0x424578['DUTFp']===_0x424578[_0x2ddd74(0x2ce)]){timeRemaining--,updateTimerDisplay();if(_0x424578[_0x2ddd74(0x176)](timeRemaining,0x0)){if(_0x424578[_0x2ddd74(0x344)](_0x2ddd74(0x29a),_0x424578['iDtRa'])){const _0x2c508b=_0x57ac06?function(){if(_0x4d78a6){const _0x377b55=_0x126fd1['apply'](_0x532ce2,arguments);return _0x5c63c9=null,_0x377b55;}}:function(){};return _0x2b7ee9=![],_0x2c508b;}else{_0x424578['VLQVd'](clearInterval,timer);if(_0x424578[_0x2ddd74(0x1e5)](currentMode,_0x424578[_0x2ddd74(0x19b)])){if(_0x424578['MkxqT'](_0x424578[_0x2ddd74(0x110)],_0x2ddd74(0x260))){const _0x1b374a=_0x264e70['parse'](_0x41a167['getItem'](_0x2ddd74(0x24a)));if(_0x1b374a){const _0x344a75=_0x520263[_0x2ddd74(0x24d)][_0x2ddd74(0x18b)]('|');let _0x55f3a4=0x0;while(!![]){switch(_0x344a75[_0x55f3a4++]){case'0':_0x2fed34=_0x1b374a[_0x2ddd74(0x1ba)];continue;case'1':_0x19b545[_0x2ddd74(0x1d5)](_0x2ddd74(0x20a))['textContent']=_0x147c1c[_0x2ddd74(0x331)];continue;case'2':_0x3fdfa5['getElementById']('quizHierarchy')[_0x2ddd74(0x1a7)]=_0x4e77a2[_0x2ddd74(0x253)](_0x2ddd74(0x26e));continue;case'3':_0x104df9=_0x1b374a['name'];continue;case'4':_0x380e2a[_0x2ddd74(0x359)]=_0x211f2d+_0x2ddd74(0x1d8);continue;case'5':_0x1bf095=_0x1b374a[_0x2ddd74(0x289)];continue;}break;}}}else _0x424578[_0x2ddd74(0x1fb)](submitQuiz);}else _0x424578['fpLZo'](_0x2ddd74(0x108),_0x424578[_0x2ddd74(0x1e3)])?nextQuestion():(_0x333de2[_0x2bc4b8][_0x2ddd74(0x1ab)]=!_0x4c8719[_0x59bba4][_0x2ddd74(0x1ab)],_0x424578['MNRgC'](_0x5ec70f),_0x5e845c());}}}else{if(_0x424578[_0x2ddd74(0x247)](_0x5e6a1c,'study')&&_0x424578['UWgQy'](_0x3a40cb,_0x424578['XZSqz']))return;const _0x117bca=_0x377525['getElementById'](_0x424578[_0x2ddd74(0x20b)]),_0x1458bd=_0x117bca[_0x2ddd74(0x201)](_0x424578[_0x2ddd74(0x1ee)]),_0x2a4e97=_0x42d938[_0x252d9f],_0x5a6c72=_0x2a4e97[_0x2ddd74(0x34f)];let _0x123750=_0x2a4e97['choices']['findIndex'](_0x568010=>_0x568010['id']===_0x5a6c72);_0x117bca[_0x2ddd74(0x146)][_0x2ddd74(0x1f1)](_0x424578['FYRhF']),_0x1458bd['forEach']((_0x4e4eef,_0xf76e3e)=>{const _0x531906=_0x2ddd74;_0x4e4eef[_0x531906(0x146)][_0x531906(0x389)](_0x520263[_0x531906(0x10d)]);if(_0xf76e3e===_0x123750)_0x4e4eef['classList']['add'](_0x531906(0x1c1));else{if(_0x520263[_0x531906(0x106)](_0xf76e3e,_0x35312b)&&!_0x45db27)_0x4e4eef['classList']['add'](_0x531906(0x318));}}),_0x424578[_0x2ddd74(0x1fb)](_0x24c872);}},0x3e8);}function updateTimerDisplay(){const _0x25fe8b=_0x148940,_0x38d6ef={'LobuO':function(_0x9cc71e,_0x508f48){return _0x9cc71e/_0x508f48;},'LyxUa':function(_0x3b839e,_0x16378b){return _0x3b839e%_0x16378b;},'lUEmF':function(_0x233392,_0xdb5f87){return _0x233392+_0xdb5f87;}},_0x576169=Math['floor'](_0x38d6ef[_0x25fe8b(0x364)](timeRemaining,0x3c)),_0x42562d=_0x38d6ef[_0x25fe8b(0x24e)](timeRemaining,0x3c);document[_0x25fe8b(0x1d5)](_0x25fe8b(0x271))[_0x25fe8b(0x1a7)]=_0x38d6ef[_0x25fe8b(0x14e)](_0x576169,':')+_0x42562d[_0x25fe8b(0x28c)]()[_0x25fe8b(0x35c)](0x2,'0');}function toggleSidebar(){const _0x5328ff=_0x148940,_0x2c1bab={'HsScN':'open'};document[_0x5328ff(0x1d5)](_0x5328ff(0x14c))[_0x5328ff(0x146)][_0x5328ff(0x153)](_0x2c1bab['HsScN']);}document[_0x148940(0x2a4)](_0x148940(0x1bc),()=>{const _0x2d5147=_0x148940,_0x2eb4fe={'HKOtu':function(_0x1de9f7){return _0x1de9f7();},'yVUjo':function(_0x100422,_0x3c8cd3){return _0x100422<=_0x3c8cd3;},'hzABG':function(_0x107b58,_0x10aa6a){return _0x107b58(_0x10aa6a);},'sHzqv':function(_0x1c64c6,_0xdd9fa6){return _0x1c64c6===_0xdd9fa6;},'wINPG':_0x2d5147(0x107),'xZcgK':function(_0x43732a){return _0x43732a();},'YREkn':function(_0x7866f){return _0x7866f();},'MOAuA':'modeModal','nxaxg':_0x2d5147(0x24c),'OrLyO':'KvFJL','ABYfD':_0x2d5147(0x1d0),'Buvxy':_0x2d5147(0x343),'HDVXT':function(_0x5bf0c2){return _0x5bf0c2();},'GfMEu':function(_0x460086){return _0x460086();}};if(resume)_0x2eb4fe[_0x2d5147(0x1ad)](loadProgress)?(document['getElementById'](_0x2eb4fe['MOAuA'])[_0x2d5147(0x373)][_0x2d5147(0x12d)]=_0x2eb4fe[_0x2d5147(0x35f)],_0x2eb4fe[_0x2d5147(0x1ad)](initializeQuiz)):_0x2eb4fe[_0x2d5147(0x302)]!==_0x2eb4fe[_0x2d5147(0x302)]?(_0xcb6b01--,_0x2eb4fe[_0x2d5147(0x1a4)](_0x1d5ad6),_0x2eb4fe['yVUjo'](_0x94d80a,0x0)&&(_0x2eb4fe[_0x2d5147(0x382)](_0x5e1dba,_0x1de64a),_0x2eb4fe['sHzqv'](_0x2442e6,_0x2eb4fe['wINPG'])?_0x49bbd8():_0x2eb4fe[_0x2d5147(0x19d)](_0x394ccb))):(_0x2eb4fe[_0x2d5147(0x19d)](clearProgress),document[_0x2d5147(0x1d5)](_0x2eb4fe[_0x2d5147(0x109)])[_0x2d5147(0x373)]['display']=_0x2eb4fe['ABYfD']);else!window[_0x2d5147(0x316)][_0x2d5147(0x16c)][_0x2d5147(0xec)](_0x2eb4fe[_0x2d5147(0x161)])?(_0x2eb4fe[_0x2d5147(0x123)](clearProgress),document[_0x2d5147(0x1d5)](_0x2eb4fe[_0x2d5147(0x109)])[_0x2d5147(0x373)][_0x2d5147(0x12d)]=_0x2eb4fe['ABYfD']):_0x2eb4fe['GfMEu'](initializeQuiz);}),document['addEventListener'](_0x148940(0x204),function(_0x299f00){const _0x51f534=_0x148940,_0x3c1551={'xrYiF':function(_0x396c3f,_0x2905e3){return _0x396c3f<_0x2905e3;},'ZPcEr':function(_0x5816ee,_0x4a22e3){return _0x5816ee/_0x4a22e3;},'skXza':function(_0x30c0f0,_0x44f660){return _0x30c0f0+_0x44f660;},'frept':function(_0x774ae9,_0x32ec5b){return _0x774ae9!==_0x32ec5b;},'KsMRl':_0x51f534(0x24c),'LnSEp':_0x51f534(0xe0),'VjuSa':function(_0x4b0f80,_0x5102d0){return _0x4b0f80>=_0x5102d0;},'XJteq':function(_0x17693e,_0x4c5591){return _0x17693e<=_0x4c5591;},'CKHaN':function(_0x2bb7c3,_0x3f86cc){return _0x2bb7c3===_0x3f86cc;},'TJhpK':'qYrLN','yrsdQ':'LDqAn','wmDvY':function(_0x11133b,_0x560bac){return _0x11133b-_0x560bac;},'lbXnP':function(_0x51ee11,_0x531cab){return _0x51ee11(_0x531cab);},'vUVWV':_0x51f534(0x314),'VHdXU':function(_0x2509a,_0x4dc4fc){return _0x2509a<_0x4dc4fc;},'xGDTG':function(_0x19953b,_0x4b5fff){return _0x19953b(_0x4b5fff);},'fzSAy':function(_0x8093ca,_0x5471a0){return _0x8093ca===_0x5471a0;},'OCjHa':_0x51f534(0x1a6),'AZkVb':function(_0x1238c1){return _0x1238c1();},'jYJLE':_0x51f534(0x2c4),'PKRDW':function(_0x15d6a0){return _0x15d6a0();},'GyJQG':function(_0x184318,_0x16c017){return _0x184318===_0x16c017;},'YMGMV':function(_0x5d0b01,_0x5275c8){return _0x5d0b01===_0x5275c8;},'nBpbX':'study','pIhKj':function(_0x3e761c){return _0x3e761c();},'iASOe':_0x51f534(0x37b),'JTmSP':_0x51f534(0x107),'VTXYW':function(_0x3509e8){return _0x3509e8();},'wvxGS':function(_0x308a95,_0x49549a){return _0x308a95===_0x49549a;},'vpYrG':_0x51f534(0xfe),'qxYoA':'pBpLk'};if(_0x3c1551[_0x51f534(0x1aa)](document[_0x51f534(0x1d5)](_0x51f534(0x121))[_0x51f534(0x373)][_0x51f534(0x12d)],_0x3c1551[_0x51f534(0x275)]))return;if(document[_0x51f534(0x1d5)](_0x3c1551[_0x51f534(0x280)])[_0x51f534(0x146)]['contains'](_0x51f534(0x1a2))===![])return;if(_0x3c1551[_0x51f534(0x31f)](_0x299f00[_0x51f534(0x22e)],'1')&&_0x3c1551[_0x51f534(0x32a)](_0x299f00[_0x51f534(0x22e)],'4')){if(_0x3c1551[_0x51f534(0x276)](_0x3c1551[_0x51f534(0x1fa)],_0x3c1551[_0x51f534(0x2cd)])){const _0x632886={'wPvET':function(_0x31329c,_0x2feb5c){const _0x3f0962=_0x51f534;return _0x3c1551[_0x3f0962(0x2ec)](_0x31329c,_0x2feb5c);}},_0x56edd9=_0x2babeb['parse'](_0x8efefe['getItem'](_0x51f534(0x324)))||[];_0x56edd9['forEach'](_0x1d9e83=>{const _0x410ee1=_0x51f534;_0x1d9e83[_0x410ee1(0x28f)][_0x410ee1(0x1a8)](_0xad7d80['toLowerCase']()[_0x410ee1(0x11d)](/ /g,'-'))&&(_0x632886[_0x410ee1(0x282)](_0x1d9e83[_0x410ee1(0x1ff)],_0x432f74[_0x410ee1(0x331)])&&(_0x1f4128[_0x1d9e83[_0x410ee1(0x1ff)]]['bookmarked']=!![]));});}else{const _0x3b6450=_0x3c1551[_0x51f534(0x1b4)](_0x3c1551['lbXnP'](parseInt,_0x299f00[_0x51f534(0x22e)]),0x1),_0x1ad091=document[_0x51f534(0x201)](_0x3c1551[_0x51f534(0x310)]);if(_0x3c1551[_0x51f534(0x15f)](_0x3b6450,_0x1ad091[_0x51f534(0x331)]))_0x3c1551['xGDTG'](selectOption,_0x3b6450);}}else{if(_0x3c1551['fzSAy'](_0x299f00[_0x51f534(0x22e)],_0x3c1551['OCjHa']))_0x3c1551[_0x51f534(0x224)](previousQuestion);else{if(_0x3c1551['CKHaN'](_0x299f00['key'],_0x3c1551[_0x51f534(0x178)])||_0x299f00['key']==='\x20')_0x299f00['preventDefault'](),_0x3c1551['PKRDW'](nextQuestion);else{if(_0x3c1551[_0x51f534(0x2bf)](_0x299f00['key'][_0x51f534(0x101)](),'b')&&(_0x3c1551['YMGMV'](currentMode,_0x3c1551['nBpbX'])||currentMode==='timed_study'))_0x3c1551['pIhKj'](toggleBookmark);else{if(_0x3c1551[_0x51f534(0x1f7)](_0x299f00[_0x51f534(0x22e)][_0x51f534(0x101)](),'m')&&(currentMode===_0x3c1551[_0x51f534(0x246)]||currentMode===_0x3c1551[_0x51f534(0x375)]))_0x3c1551['VTXYW'](toggleMarkForReview);else{if(_0x299f00[_0x51f534(0x22e)][_0x51f534(0x101)]()==='s'&&(_0x3c1551[_0x51f534(0x214)](currentMode,_0x3c1551[_0x51f534(0x246)])||_0x3c1551[_0x51f534(0x355)](currentMode,_0x3c1551[_0x51f534(0x375)]))){if(_0x3c1551[_0x51f534(0x276)](_0x3c1551[_0x51f534(0x185)],_0x3c1551[_0x51f534(0x38d)])){const _0x27db3c=_0x318223[_0x51f534(0x10f)](_0x3c1551['ZPcEr'](_0xd43c46,0x3c)),_0x5b7fce=_0x4f6e4e%0x3c;_0x9c46ab['getElementById'](_0x51f534(0x271))[_0x51f534(0x1a7)]=_0x3c1551['skXza'](_0x27db3c,':')+_0x5b7fce['toString']()['padStart'](0x2,'0');}else submitQuiz();}}}}}}});</script>

</body></html>